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ABSTRACT

A SIMULATION-BASED APPROACH FOR EVALUATING
GENE EXPRESSION ANALYSES

Carly R. Pendleton
Department of Statistics
Master of Science

Microarrays enable biologists to measure differences in gene expression in thousands of genes simultaneously. The data produced by microarrays present a statistical
challenge, one which has been met both by new modifications of existing methods
and by completely new approaches. One of the difficulties with a new approach to
microarray analysis is validating the method’s power and sensitivity. A simulation
study could provide such validation by simulating gene expression data and investigating the method’s response to changes in the data; however, due to the complex
dependencies and interactions found in gene expression data, such a simulation would
be complicated and time consuming. This thesis proposes a way to simulate gene expression data and validate a method by borrowing information from existing data.
Analogous to the spike-in technique used to validate expression levels on an array,
this simulation-based approach will add a simulated gene with known features to
an existing data set. Analysis of this appended data set will reveal aspects of the
method’s sensitivity and power. The method and data on which this technique is
illustrated come from Storey et al. (2005).
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1. INTRODUCTION

The biological systems that create and maintain life are intensely complex. They
are difficult to study because many interdependent biochemical systems are present.
Many of the seminal experiments in biology involved entire organisms and were considered “black boxes”—the organism itself could be observed but the components
that determine the organism’s functions remain a mystery. Over the past century,
biologists have been slowly breaking the black boxes into smaller and smaller pieces,
eventually arriving at the molecular level. Duplicating “life” requires understanding how thousands of these black boxes interact. Studying bits of real life requires
monitoring hundreds and even thousands of chemical reactions that mostly occur
simultaneously in a vast network of checks and balances. Microarrays are revolutionizing biology research by allowing researchers to design and analyze experiments that
do just that.

1.1

Basic Molecular Biology
Microarrays were designed as a response to the need to analyze gene expression

data. Consequently, a basic understanding of molecular biology becomes useful in
understanding how the data are collected and how they should be handled. This
section will introduce the main concepts of molecular biology and how they relate to
microarrays.

1.1.1

The Central Dogma
To understand the technology and strategy behind microarrays, it is important

to first understand the central dogma—the organizing principle behind molecular
biology. James Watson and Francis Crick, famous for their discovery of DNA’s double
1

helix structure, proposed the idea of the central dogma in 1958. Originally more of an
afterthought than a core theory, Watson’s first representation of the central dogma
was no more than a note on a scrap of paper:
The idea of genes being immortal smelled right, and so on my wall
above my desk I taped up a paper sheet saying DNA→RNA→protein.
The arrows did not signify chemical transformations, but instead expressed the transfer of genetic information from the sequence of nucleotides in DNA molecules to the sequences of amino acids in proteins.
—Watson (2001)
The term “dogma,” attributed to Crick, has often been criticized for its strict
connotation. Crick intended it to be used with a looser definition:
[An associate] pointed out to me that I did not appear to understand
the correct use of the word dogma, which is a belief that cannot be
doubted. . . . I used the word the way I myself thought about it, not as
most of the world does, and simply applied it to a grand hypothesis
that, however plausible, had little direct experimental support.
—Crick (1988)
In the fifty years since the proposal of the central dogma, substantial evidence
has been found in its favor and even the most rigorous definition of dogma is felt to be
appropriate. When Watson and Crick submitted a paper to Nature in 1953 claiming
to know the structure of DNA, the paper “was not peer-reviewed by Nature. . . the
paper could not have been refereed: its correctness is self-evident. No referee working
in the field . . . could have kept his mouth shut once he saw the structure . . . ” (Maddox
2003).
The central dogma is often illustrated by a simple diagram (see Figure 1.1).
Information is transferred from DNA to RNA to proteins.1 Proteins, the final product
1

In his 1970 Nature paper, Crick suggested that other transfers of information may be possible,
such as RNA → DNA. Since then, this pathway has been synthesized using the enzyme reverse
transcriptase. DNA created using RNA as a template is called complementary DNA (cDNA).
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Figure 1.1: The central dogma of biology. The founding principle of molecular biology
is the transfer of information from DNA to RNA to proteins. The transfer from DNA
to RNA takes place in the nucleus—the control center of the cell. The transfer from
RNA to protein takes place in the cytoplasm—the area of the cell outside the nucleus.

of this information transfer, participate in the pathways that govern life in all living
organisms. Though DNA and RNA have little, if any, physical participation in these
pathways, they contain the instructions necessary to create the proteins. All three
pieces of the central dogma are essential for life. Disruption of this transfer would, if
unresolved, destroy an organism quickly and irreversibly.

1.1.2

DNA and Replication
Deoxyribonucleic acid (DNA) is the first component of the central dogma.

Though microscopic, the genetic information contained within the DNA of a single
human cell includes all the information necessary to start, stop, and regulate every
function of the body. DNA controls the color of one’s hair, serves as the template for
antibodies against the common cold, works together with proteins to monitor growth,
and is the material of inheritance passed on from parent to child.
The subunits of a DNA molecule are nucleotides. Nucleotides, in turn, are made
up of a sugar, a phosphate group, and a base. The sugar, deoxyribose, is common to
all nucleotides found in DNA. The name deoxyribose literally means ribose (a sugar
molecule) with an oxygen atom removed. The presence or absence of this oxygen
atom is one of the key differences between DNA and RNA, discussed below. The
3

phosphate group also has the same basic structure for all nucleotides and serves as
the connector between nucleotides. The base, however, has four varieties: adenine
(A), guanine (G), cytosine (C), and thymine (T).

Figure 1.2: The four DNA nucleotides. All nucleotides have a pentagonal carbon ring
(bottom left of each nucleotide). The difference between purines and pyrimidines lies
in the ring(s) connected to the base ring. Purines have two rings (top right of purines)
while pyrimidines have only one ring (top right of pyrimidines).

Figure 1.2 displays the atomic structure of the four bases. Adenine and guanine
are composed of two fused rings; these are called purines. Cytosine and thymine have
only one ring; these are pyrimidines. Another pyrimidine, uracil, is not found in
DNA but plays an important role in RNA. Through various combinations of these
four bases, infinite sequences are possible, allowing for the remarkable versatility of
DNA; a sequence of only 10 bases would allow 410 or 1,048,576 possible sequences.
Considering that the human genome—the entire set of DNA required for a living
organism—contains over 3 billion bases, it is no wonder that no two organisms are
alike.
DNA is a double helix; that is, it contains two strands wound around each
other in a spiral structure (see Figure 1.3). These strands are composed of linked
nucleotides. Each phosphate group in a nucleotide is bonded to the sugar of the nucleotide as well as to the sugar of its neighboring nucleotide. This sugar-phosphatesugar link creates the backbone of DNA. Figure 1.4 illustrates the pattern of nucleotide linkage in the DNA backbone.
4

Figure 1.3: Deoxyribonucleic acid. Deoxyribonucleic acid (DNA) is a double-stranded
structure twisted in a helical shape. The “rungs” represent base pairs.

Figure 1.4: Deoxyribonucleic acid—molecular structure. DNA’s backbone consists of
sugar molecules and phosphate groups linked together; the bases are bonded to the
backbone while maintaining free atoms to bond with complementary bases on the
other strand.

5

The sugar and the phosphate group are used to connect the nucleotides of a
single strand, while the bases of the two strands of DNA pair with each other. Each
pair of bases forms a link between the two strands of DNA, much like the rungs of a
ladder connect its sides. Purines are bulkier than pyrimidines because they have two
rings versus one ring (see Figure 1.2). Therefore, a purine must pair with a pyrimidine
to preserve a uniform distance between the two strands.2 Slight differences among
the bases dictate which base pairs are possible: adenine pairs only with thymine and
cytosine pairs only with guanine. In an adenine-thymine pair, two hydrogen bonds
are formed; in a guanine-cytosine pair, three hydrogen bonds are formed. The bonds
formed by these pairs are shown in Figure 1.5. This specific pairing pattern requires
a sequence of DNA on one strand to have an exact complementary sequence on the
other strand. Should the two become separated, the cell would be able to recreate the
other strand using the existing strand as a template. Watson and Crick recognized
this feature of DNA when they originally proposed its structure in 1953: “It has not
escaped our notice that the specific pairing we have postulated immediately suggests
a possible copying mechanism for the genetic material” (Watson and Crick 1953).

Figure 1.5: Base pairings in DNA. Adenine pairs with thymine and guanine pairs
with cytosine. The dotted lines represent hydrogen bonds.

2

Initially, Watson and Crick hypothesized that purines paired with purines and pyrimidines
paired with pyrimidines; this would cause the double-stranded DNA to weave in (at pyrimidinepyrimidine pairs) and out (at purine-purine pairs); however, another scientist researching the structure of DNA, Rosalind Franklin, had produced x-ray photographs of DNA inconsistent with this
proposal by Watson and Crick. Franklin’s data was given to Watson and Crick, without her knowledge, and with the additional information Watson and Crick were ultimately able to postulate the
correct structure of DNA (Stasiak 2003).
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For cell growth and maintenance, DNA must replicate itself periodically. As
cells grow and divide, they pass on a copy of their DNA to their offspring, or daughter
cells. The complementary pairing of bases provides for exact replication of a strand of
DNA. In this way, a cell can make duplicates of its DNA and distribute the duplicates
as it divides, giving rise to cells that are identical in every way to the original cell.
The replication process begins with two parent strands separating by breaking
the bonds between bases. Once a portion of the strands are separated, mechanisms
within the cell identify which base pair is needed to match the now unpaired base on
the parent strand. A new strand is built by selecting the appropriate nucleotide to
match the parent strand and forming new bonds between the bases. This process of
unwinding the strands, finding a new base, and forming new bonds continues along
the entire length of the DNA molecule. When the process is completed, two doublestranded daughter DNA molecules are generated, exact replicates of the parent strand.
Replication is shown in Figure 1.6.

Figure 1.6: The replication process. The double-stranded DNA is separated, and
each strand is replicated separately, creating two duplicate sets of DNA.

Each cell, regardless of its specific function, contains the organism’s entire
genome. The information required for the heart to pump continuously is contained
in every cell, including skin cells, bone cells, and muscle cells; however, only certain
portions of the genome are “turned on” in a given cell, giving rise to differentiation.
7

1.1.3

RNA and Transcription
The second component of the central dogma is ribonucleic acid (RNA). RNA

is structurally very similar to DNA; both are nucleic acids—chains of nucleotides.
Despite these similarities, there are several key differences between RNA and DNA:
RNA is single-stranded, whereas DNA is always double-stranded; RNA uses a slightly
different sugar, ribose, in its structure; and RNA uses the pyrimidine uracil (U) in
place of thymine.
The central dogma suggests that the information in DNA is copied into RNA.
Transcription is the process in which a strand of DNA is used as a template to create a
new strand of RNA. This process is similar to DNA replication, but in replication, the
entire genome is replicated. In transcription, only the portions of DNA that contain
the information necessary for the functions of a particular cell are transcribed into
RNA. For example, in epidermal cells, the DNA that codes for melanin—the pigment
that gives skin color—will be transcribed, but the DNA that codes for insulin—a
hormone that aids in sugar breakdown—will not be transcribed. RNA is usually
found in short strands, each containing the code for a single gene, a portion of DNA
that codes for a functional protein (Lodish et al. 2000). Once again, it is important
to note that the original sequence of bases found on a parent DNA strand is preserved
throughout replication and transcription.
Transcription takes place in three steps: initiation, elongation, and termination
(see Figure 1.7). In all three steps a protein called RNA polymerase directs the
process. Transcription is initiated when the polymerase recognizes a region of DNA
called a promoter. The polymerase attaches to the RNA at the promoter and begins
separating the DNA strands. Just “downstream” of the promoter is the start site
where the polymerase begins building the RNA chain. Once a few nucleotides have
been joined, elongation begins. The polymerase leaves the promoter and moves down
the DNA strand, adding corresponding nucleotides to the growing RNA chain. The
8

newly created RNA does not stay bound to the DNA, rather, it detaches a few bases
behind the polymerase. The separated DNA strands rewind behind the polymerase
as the portion is transcribed. Eventually the polymerase approaches a region of DNA
called the terminator. The terminator signals to the polymerase to release the DNA
template and the newly created RNA strand. At this point, transcription is complete.

Figure 1.7: The transcription process. RNA polymerase builds a chain of RNA
complementary to the template DNA.

Although it does not occur naturally within the cell, DNA can be created from
RNA. This process, known as reverse transcription, uses the enzyme reverse transcriptase from retroviruses. Reverse transcriptase produces a strand of DNA complementary to a strand of RNA (reversing the usual procedure) (Lodish et al. 2000).
RNA includes the code for only the genes which will be activated in a particular cell;
therefore, reverse transcription provides the DNA for active genes. If the DNA were
extracted directly from the cell and not created via reverse transcription, it would
contain the code for all genes, not just those genes being synthesized. By reversing
the transcription process and creating new DNA from RNA (called cDNA), a copy of
DNA can be obtained that excludes all unused material. cDNA is an important tool
in implementing the methods of microarrays.

9

1.1.4

Protein and Translation
Proteins are the final element of the central dogma. While DNA and RNA are

strings of nucleotides, proteins are strings of amino acids. Just as different combinations of the four nucleotides allow infinite possibilities in DNA, various sequences
of twenty amino acids provide for great diversity among proteins. At the core of the
central dogma is the idea that the code found in DNA is passed through RNA to
create proteins. From DNA to RNA, the code is preserved base for base; from RNA
to protein, the sequence is “translated” from nucleotides into amino acids.
Much like translating between two languages, translation in the cell converts
the RNA sequence into an amino acid sequence. Every three base pairs in either RNA
or DNA make up a codon. Each codon codes for a single amino acid (see Table 1.1).
The cell machinery scans RNA, picking off one codon at a time and finding the
corresponding amino acid. Once a chain of amino acids has been connected, it is
referred to as a polypeptide, or protein. Proteins are the products that perform tasks
within the cell.
Because amino acids are determined by sets of three base pairs, three different
proteins can be created depending on where the protein is started. The actual sequence used to create the protein is called the reading frame. For example, a segment
of RNA—AGGUACCUGUA—could code for three amino acid combinations: ArgThr-Trp if AGG is used as the first codon, Gly-Thr-Cys if GGU is used as the first
codon, and Val-Pro-Val if GUA is used as the first codon (see Figure 1.8). In most
organisms, only one reading frame is ever used; however, some viruses and phages
have developed overlapping reading frames, increasing the number of proteins that
can be created from a single sequence of DNA.
Proteins are the gene products conducting the work of the cell. A change in a
single protein may cause a vital pathway to malfunction. These changes may result
from mutations within the proteins themselves, or mutations in the DNA or RNA,
10

Figure 1.8: Reading frames. Three different proteins (strings of amino acids) can be
created from a single sequence of RNA depending on which reading frame is used.

Table 1.1: Amino acid coding chart. Every set of three nucleotides is called a codon
and corresponds to an amino acid. The left column indicates the first nucleotide, the
top row indicates the second nucleotide, and the third nucleotide is found within each
table cell. As there are more possible codons than amino acids, more than one codon
will often code for a single amino acid.
U
U

C

A

G

UUU
UUC
UUA
UUG
CUU
CUC
CUA
CUG
AUU
AUC
AUA
AUG
GUU
GUC
GUA
GUG

C

Phe

Leu
)
Leu


Ile
Met
)
Val

UCU
UCC
UCA
UCG
CCU
CCC
CCA
CCG
ACU
ACC
ACA
ACG
GCU
GCC
GCA
GCG

A
UAU
UAC
Ser
UAA
UAG
CAU
)
CAC
Pro
CAA
CAG
AAU
)
AAC
Thr
AAA
AAG
GAU
)
GAC
Ala
GAA
GAG
)

G

Tyr
Stop
Stop

His

Gln

Asn

Lys

Asp

Glu


UGU
Cys
UGC
UGA Stop
UGG Trp
CGU )
CGC
Arg
CGA
CGG 
AGU
Ser
AGC 
AGA
Arg
AGG
GGU )
GGC
Gly
GGA
GGG

U
C
A
G
U
C
A
G
U
C
A
G
U
C
A
G
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disrupting the code that would eventually be translated into protein. For example,
sickle-cell disease is a result of a single base change from adenine to thymine. Although
only one base is changed, the corresponding amino acid is also changed, causing the
protein to be altered. This disease causes those who have this mutation to have
sickle-shaped red blood cells. Under certain conditions, these blood cells will burst,
causing potentially fatal anemia.
To investigate which proteins are created in a cell, the proteins can be cataloged
or the RNA coding for the proteins in the cell can be examined. With thousands of
proteins present in a cell at any given time, extracting and identifying the proteins in
a cell is a drawn-out and tedious process. Extracting RNA is more practical. RNA
is a much smaller molecule than a protein, yet it still contains all the information
about the cell. Because of these features, RNA is a surrogate measure of the protein
activity in an organism and is often used in gene expression studies.

1.2

Microarrays
The ability to measure differences in gene expression has been a goal of biologists

for many years. Until recently, however, this goal has been difficult to attain. With
thousands of genes in a living organism, the time it would take to extract individual
genes and compare them on a normalized scale is daunting. In the past, scientists
have worked around this problem by examining a few genes at a time. Without the
ability to compare expression levels of thousands of genes, pathways could not be
identified, the expression of important genes could be overlooked, and progress could
only be made in very small steps.
With the establishment of the Human Genome Organization in 1989, the demand for a method to measure differential gene expression increased greatly. Within
ten years, “researchers [had] catalogued more than 1.1 million expressed seqence
tagged sites (ESTs), corresponding with 52,907 unique human genes” (Duggan et al.
12

1999). However, the function of the majority of these genes remained unknown. In
response to the desire to identify the expression and regulation of sequenced genes,
the microarray was developed. Though only the size of a microscope slide, microarrays are capable of comparing up to 100,000 genes simultaneously. At first, the arrays
could only be used sparingly, as each chip cost about $1,000,000 to create (Müller and
Röder 2006, p.1). Now, lowered costs have increased the popularity of microarrays.
The name is well suited to the method, as “micro” means small and “array” refers
to an impressively large assembly. Since their development, microarrays have rapidly
become a widely used tool. In just the past ten years, over 30,000 articles have been
published concerning microarrays and microarray studies.

1.2.1

Studying Gene Expression
Prior to the introduction of the microarray, several methods existed to iden-

tify the function of a gene. Though each has proved inefficient in assessing several
thousand genes at once, they are useful when working with smaller numbers of genes.
Most of the methods for studying gene expression at the nucleic acid level utilize
the phenomenon of hybridization. Hybridization is the ability of single-stranded DNA
or RNA to bond with another single strand to form a double helix. This will only
occur when the two strands are complementary in their base pair pattern; that is, the
bases of one strand pair with the bases of the other strand along their entire length.
Northern blots is one technique that uses hybridization to measure gene activity.
The Northern blot technique collects RNA from the organism of interest. The
sample containing the RNA is inserted into a gel, similar to a thin sheet of jello. An
electric current draws the sample through the gel, separating the RNA based on size.
The RNA is then “blotted,” or transferred, onto a filter through diffusion. cDNA
from a gene of interest is labeled with a fluorescent or radioactive tag. The labeled
cDNA is then hybridized to the RNA on the filter. If the complementary RNA is

13

present, the cDNA will bind to it, forming a double helix. If the RNA is not present,
the cDNA will not hybridize and will be washed off the filter. When the filter is
passed through the appropriate steps to visualize the labeled cDNA, it becomes easy
to see whether the gene is present in the sample and relative amounts of the gene;
the darker the mark, the more RNA present. Figure 1.9 displays these dark marks
on a Northern blot. Although all the RNA in a sample is present on the filter, only
the RNA complementary to the probe will be visualized. For this reason, only one
transcript of RNA can be investigated at a time.

Figure 1.9: A Northern blot. The dark marks indicate where probed RNA is present.
Larger strands of RNA move further down the gel than smaller strands.

Northern blot results provide information about the presence and quantity of
sample RNA extracted from an organism; however, they do not give any indication
of how the sample RNA affects the entire organism. Researchers are often interested
in how the gene affects the life of the organism as a whole. Gene knockouts are one
way to measure the function of a gene.
Knockout mice are a common example of the knockout technique. To begin,
mouse DNA is cloned to contain a disrupted copy of the gene of interest. This
engineered mouse DNA is then mixed with embryonic stem cells (fertilized cells that
have undergone little development) from a mouse. As a result, a few stem cells will
contain the disrupted gene. These are selected using several identification markers and
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then inserted into a surrogate mother where they finish development. The surrogate
mother will give birth to mice with a mutant copy of the gene. These mice can be
observed to see the effect this gene has over their lifetime.
Both Northern blots and knockout mice are useful techniques when examining a single gene; however, a separate blot or knockout mouse must be created for
each gene of interest. Knockout organisms have the potential to inactivate three or
more genes at a time, but this number is limited by available markers (Mortensen
1993). Should the interest lie in a large number of genes, or if a study is largely
exploratory, Northern blots and knockouts are inadequate. The Complex Trait Consortium project uses an eight-way cross of inbred mice lines to generate great genetic
diversity available for study; however, this method requires great quantities of mice
and is limited computationally and statistically (Williams et al. 2002). A study aided
by microarrays can overcome many of these limitations.

1.2.2

The Microarray Process
At first glance, a cDNA microarray looks very much like an ordinary microscope

slide. A closer look, however, will reveal thousands of tiny spots arranged in a rectangular grid. Each spot contains a piece of cDNA from a given organism’s genome.
A single microarray may contain an entire genome.
cDNA microarrays are constructed using replicated cDNA clones and precise
printing machinery. Again, cDNA is DNA created using RNA as a template. The
cDNA are replicated by polymerase chain reaction (PCR), a process that can amplify
one double-stranded segment of DNA into thousands of segments in a relatively short
period of time. Each replicated sample is contained in a well; each well holds thousands of copies of the sample. The wells are arranged in grids, ready to be dipped
into and printed on the array.
When the array is complete, nearly 20,000 spots have been meticulously printed
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onto the small slide. Each dot is not necessarily unique; common practice places the
same sample in different locations on the slide to control for error in array location.
Meanwhile, in the lab, the samples, or targets, are prepared to react with the
array. Each microarray is capable of comparing two targets. The selection of these
two targets depends on experimental design. For example, an experimenter may want
to use a control subject for the first target and a treated subject for a second target.
This allows different treatments to be compared relative to the control. A loop design
may compare treatment A to treatment B on the first array, treatment B to treatment
C on the second array, and so on (see Figure 1.10).

Figure 1.10: Examples of experimental design using microarrays. A reference design
compares each treatment to a control, while a loop design compares each treatment
to the other treatments (Simon et al. 2003).

Once two targets have been selected for comparison on a microarray, the mRNA
is extracted and reverse-transcribed to obtain cDNA. Each target is labeled with
a fluorescent marker, typically green or red. The samples are combined in equal
amounts and the mixture is pipetted onto the prepared microarray. The samples
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hybridize to the probes on the array.

Figure 1.11: Scanned image of a microarray. Each colored dot represents a different
probe. Red dots indicate that more of the red sample is present, green dots indicate
that more of the green sample is present, and yellow dots indicate that equal amounts
of both samples are present. The brightness of a spot indicates the quantity of the
sample present.

After the samples hybridize to the microarray, a scanner quantifies the extent
of hybridization. Microarray scanners are able to measure the fluorescence emission
intensity of the markers for each spot on the array. Figure 1.11 shows a microarray
with hybridized red and green samples. Two numerical quantities are assigned to
each spot, one for the red intensity and one for the green intensity, corresponding to
the two samples. The ratio of these intensities provides the relative expression of the
two samples. It is this ratio which indicates the differential gene expression between
the two samples.
This process describes only one type of microarray, the cDNA microarray. Several other types of arrays are available. Affymetrix GeneChip arrays provide several
probes for each gene, including copies of altered genes to measure specificity. Agilent
arrays offer flexibility by printing a standard set of genes on the majority of the array
but leaving a portion of the array blank so that scientists can add their own probes.
For the remainder of this paper, cDNA arrays will be assumed for all experiments.
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1.2.3

Analysis Methods
Most microarray analysis methods started as ad hoc ideas and have evolved into

theoretically sophisticated techniques. The methods described here are among those
generally accepted for data involving independent microarray data.

1.2.3.1

Preprocessing

Raw microarray data is rarely ready for immediate analysis. The human element of creating microarrays often introduces irregularities in the data. Variation in
the data introduced by sources other than those factors being studied must be accounted for in order for the analysis to be useful. Preprocessing techniques attempt
to standardize microarray data so that the analysis results can be compared.
First, numeric data must be extracted from the microarray image. The intensity of each scanned pixel is collected; image analysis software categorizes each
pixel in the image as belonging to the sample or to the slide (foreground or background, respectively). The data includes some background noise usually resulting
from the scanning process. To account for this noise, image processing software will
subtract the background value from the intensity measurement. This technique can
be problematic because it introduces additional variability in the measurement. Some
methods recommend avoiding background subtraction if it does not seem necessary
(Parmigiani et al. 2003, p.14).
Several sources of variation introduce artificial differences among arrays. These
sources include unequal sample preparation, irregularities in the printing machinery,
and an uneven distribution of the sample on the array. Normalization of the data is
necessary in order to compare data across arrays.
One source of variation that requires normalization is the printing machinery.
The printing machinery consists of a print-head containing a number of print-tips.
Figure 1.12 shows a microarray printer. Each print-tip has a tiny hole that enables
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it to draw fluid from the prepared wells. When each of the print-tips contains fluid,
the print-head moves over to the microarray and “prints” dots of cDNA in a grid
corresponding to the grid setup of the print-tips.

Figure 1.12: A microarray printer. Print tips place probe samples on designated spots
on the array.

Because the printing machinery is prone to be inconsistent in the size of the
sample it prints on each array, one array may receive a greater amount of the RNA
sample than another array, leading to overall greater intensity levels. This does not
necessarily mean that the first sample has greater transcription levels than another;
normalization will produce comparable expression levels for all arrays.
Quality assessment is an important task of preprocessing. The data must be
investigated for irregular measurements beyond the scope of random fluctuations.
Diagnostic plots provide a visual tool for assessing the quality of the data. MA
plots display differential expression in terms of log-ratios, M , against average log
intensities, A. One of the most commonly used visual diagnostics, MA plots are
useful in detecting intensity biases (Parmigiani et al. 2003). Figure 1.13 shows MA
plots before and after normalization. This plot reveals smaller average intensities
for spots with larger differences between channels. Most likely an artifact of the
experiment, this problem can be adjusted by normalization.
Another useful visual tool is the boxplot. Comparative boxplots of the log19

Figure 1.13: MA plots. The difference in log intensities between the two channels (M)
is plotted against average log intensity of the two channels (A). Prior to normalization,
this MA plot reveals an intensity bias.

intensities for each print tip demonstrate variations in intensity levels within an array,
while boxplots of log-intensities for each array demonstrate variations in intensity
levels between arrays. Boxplots with significantly different ranges of intensities stand
out clearly in this display. Figure 1.14 displays boxplots of relative expression by
print-tip. Most of the print-tips have similar ranges of expression levels, but print-tip
(3,3) seems to have a larger mean and greater spread than the others. This could be
the result of an old or defective print-tip, and would elicit further investigation before
its corresponding data would be accepted.

1.2.3.2

Clustering Methods

One common goal in gene expression analyses is the determination of biologically similar groups of genes. Experiments investigating this goal attempt to group
genes with similar developmental roles together. A goal of many microarray experiments is to classify subsets of genes with similar expression patterns. Hierarchical
clustering, K-means, self-organizing maps, and gene shaving are all clustering methods used in microarray studies.
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Figure 1.14: Boxplots of log-ratios by print-tip group. Print-tip group (3,3) appears
to have a larger spread and greater mean than the other print-tip groups.

Hierarchical clustering is often referred to as a “tree.” The tree has a root node
containing all of the elements in the data set. From this root emerge branches, similar
to the branches of a family tree. At each split (where two branches emerge from one),
a decision rule sorts the elements of the data into smaller groups. There are two ways
to “grow” a hierarchical tree: divisive and agglomerative. Divisive trees are built
by beginning with the root node and partitioning into smaller and smaller groups.
Agglomerative trees build clusters in the opposite direction, beginning with individual
elements and combining like pieces until a root node is composed.
In Figure 1.15, Eisen et al. (1998) group an image of genes with their expression
levels via hierarchical clustering. With thousands of genes examined simultaneously, it
is difficult to see the big picture. Graphics such as these reveal the basic organization
of all the genes in a study and help researchers decide which groups to investigate in
future studies.
A hybrid technique for clustering similar genes has also been considered. In this
technique, a hierarchical tree is initially grown divisively, but at each step the nodes
are evaluated and combined if they are determined to be more similar than differ-
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ent. The HOPACH algorithm (van der Laan and Pollard 2003) uses this alternating
partitioning and collapsing to create a hierarchical tree. The HOPACH (Hierarchical
Ordered Partitioning and Collapsing Hybrid) algorithm to choose the number of divisions to create at each node, which clusters to combine, and which clusters to keep
as the main clusters. This algorithm utilizes the median split silhouette criterion
(Pollard and van der Laan 2002a), a technique for selecting the number of clusters,
to accomplish these tasks. One of the strengths of HOPACH is its ability to create a
non-binary tree; it is not limited to binary splits, but can split a parent node into as
many daughter nodes as deemed necessary.
K-means is another clustering algorithm designed to organize data without
making any distributional assumptions. The goal is to divide the data into K clusters
such that the within-cluster sum of squares is minimized. This algorithm recognizes
the impracticality of minimizing the global sums of squares in a large data set due to
the enormous amount of possible partitions; consequently, local minima are sought
and the results are deemed sufficient.
The K-means algorithm iteratively moves points from one cluster to another
until no further move will reduce the within-cluster sums of squares. The initial set
of K clusters is chosen arbitrarily such that each cluster contains at least one point and
the mean of each cluster is computed. Each point is evaluated to determine if withincluster sums of squares can be reduced by moving the point to a different cluster.
This process is repeated until the within-cluster sums of squares are minimized.
K-means is a simple, efficient algorithm requiring few assumptions about the
data. It does, however, have some limitations. Unlike the HOPACH algorithm, the
number of clusters must be specified prior to classifying the data. Hence, K-means
should only be used if the researcher has a priori information about the number of
clusters.
Like hierarchical clustering and K-means, self-organizing maps (SOM’s) seek to
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Figure 1.15: An example of hierarchical clustering from Eisen et al. (1998). Data
comes from an experiment involving fibroblasts deprived of serum for 48 hours. Following the reintroduction to serum, samples were taken over time. The clusters
represented by the letters contain genes involved in (A) cholesterol synthesis, (B) the
cell cycle, (C) the immediate early response, (D) signaling and angiogenesis, and (E)
wound healing. Similar expression patterns are observed across time within each of
these five groups.
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discover the underlying structure or pattern in a data set. SOM’s, however, have a
number of benefits over these other methods when clustering gene expression data.
Less structured than the rigid hierarchical clustering, but more structured than the
unassuming K-means, SOM’s have proven to be more robust than either alternative
method.
SOM’s are created by first defining a geometric space such as a grid. The genes
are initially randomly mapped into k-dimensional space, where k is the dimension of
the data (not to be confused with the K clusters of K-means). The observations are
then processed one at a time. The first observation is selected and the closest node is
adjusted to become more like the selected observation. The other nodes are adjusted
as well, but with weights proportional to their distance from the observation. All the
observations are likewise processed until all the nodes have been adjusted to better fit
the data. This makes up one iteration of the SOM method. The process is repeated
several thousand times until some threshold distance between all the nodes is reached.
The result is a set of nodes where those closest to each other are most alike, and those
farthest away are most different. Figure 1.16 displays this process.

Figure 1.16: The SOM process (Tamayo et al. 1999). Numbered circles represent
initial nodes; arrows are the paths taken during iterations as nodes approach final
destination. Black dots represent data points.
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Akin to hierarchical clustering, gene shaving (Hastie et al. 2000) extracts subsets
of genes with related expression patterns and large variation across the conditions
being studied. Unlike hierarchical clustering, gene shaving allows genes to fall in
more than one subset. The algorithm behind gene shaving requires a predefined α
(proportion of genes to be “shaved” at each iteration) and M (the maximum number
of final clusters).
The first step of the gene shaving algorithm is to center the X matrix of gene
expression so that each row has a mean of 0. Next, compute the leading principal
component of each row. Remove, or “shave,” α of the genes with the smallest absolute
inner-product with the leading principal component. Then, continue computing principle components and shaving genes until only one gene is left. With each iteration,
a new subset of genes is formed (SN ⊃ Sk ⊃ Sk1 ⊃ . . . ⊃ S1 , where k is the number
of genes in the subset.) The optimal cluster, Sk̂ , is estimated using a gap statistic
defined to find the most correlated cluster of genes. Each row of X is orthogonalized
to x̄Sk̂ , the mean expression of Sk̂ . Finally, the entire process is repeated, finding a
new cluster with each iteration, until M clusters have been found. Like hierarchical
clustering, gene shaving can be unsupervised; however, if information known a priori about the data is useful in determining clusters, gene shaving has a supervised
counterpart.

1.2.3.3

Inference

Despite its relative newness, microarray technology has triggered a large collection of literature regarding its analysis. Although the proposed methods are too
numerous to include in the scope of this thesis, a few prominent models merit some
further description.
Although the two-sample t-test is a good initial approach to microarray analysis,
it has proved problematic. Gene expression data often has very small variances re-
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sulting from small expression levels, causing the test statistic to “blow up.” Inspired
by the shortcomings of the two-sample t-test, Significance Analysis of Microarrays
(SAM) was proposed by Tusher et al. (2001). SAM defines the relative difference
between two samples as
d(i) =

ȳ1 (i) − ȳ2 (i)
,
s(i) + s0

where ȳj (i) is the average expression for gene i in state j, s(i) is the standard deviation
of repeated expression measures, and s0 is a small constant added to make sure d(i)
is independent of s(i), avoiding the variance problem of the t-test. To determine the
distribution of d(i), random permutations of the data give replicates from which to
estimate a null distribution. For example, if there are two samples in an experiment,
the SAM method will permute the two samples for each gene. The new permuted
data set will exhibit null properties. Using these random permutations, the expected
relative difference under the null hypothesis, dE (i), is computed as the average of
the d(i) for each permutation. The d(i) for each gene is compared to dE (i) and a
threshold, δ, is used to determine which genes are significant. For example, δ = 1.2
would declare genes greater than 1.2 units away from dE (i) significant. The choice of
δ can be asymmetric (different for repressed genes and induced genes) if the behavior
of repressed versus induced genes is determined to be different. The choice of δ can
be somewhat arbitrary, but it is important to note that δ has an inverse relationship
with FDR: as δ increases, FDR decreases. While SAM has been criticized for the
somewhat ad hoc introduction of δ, the method performs as well as or better than
other available methods.
In the production of a microarray, there are several sources of experimental
error. Kerr et al. (2000) propose traditional ANOVA methods to account for these
sources of variance and give normalized data to be used for clustering or any further
analysis.
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The proposed model is:

log(yijkg ) = µ + Ai + Dj + Tk + Gg + (AG)ig + (T G)kg + ijkg ,
where µ is the overall average expression, Ai is the array effect, Dj is the dye effect,
Tk is the treatment effect, Gg is the gene effect, (AG)ig is the combined array and
gene effect, and (T G)kg is the interaction between treatment and gene. The other
two-, three-, and four-way interactions are left out of the model in order to leave
more degrees of freedom for error variance estimation. The effect of interest is the
interaction between treatment and gene; the others are all ancillary. The treatmentgene interaction identifies which genes are differentially expressed across treatment, or
variety.3 By including the terms Ai , Dj , and Tk in the model, data normalization and
analysis occur simultaneously. These parameters are estimated using least-squares
estimates and several model constraints.
In contrast to the methods above which are all founded in frequentist ideas,
a Bayesian method provides a natural approach to the uniqueness of microarray
data sets involving few replications but large numbers of parameters. Additionally,
an Empirical Bayes method solves the task of determining prior distributions for
hundreds of parameters by using the data to estimate unknown parameters. In the
method proposed by Kendziorski et al. (2003), two parametric families are considered
for the distribution of the data: Gamma distributed measurements and log-normal
distributed measurements.
The goal of this parametric Empirical Bayes method is to estimate a predictive
density for gene expression. This is accomplished by first dividing the data according
to a given pattern (e.g. treated versus control). The marginal distribution of the data
3

Kerr et al. (2000) use variety in place of treatment in the model, resulting from historical habit;
the foundational ANOVA model was motivated by and frequently used in agricultural studies.
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is found by
m
X

pk fk (dg ),

k=0

where pk is a set of mixing parameters and fk (dg ) is the joint density for pattern k
under the alternative hypothesis of different mean expression levels for each group.
The posterior probability of expression pattern k is found by
P (k|dg ) ∝ pk fk (dg ).
More informatively, the posterior odds in favor of pattern k for gene g is
oddsg,k =

pk
fk (dg )
.
1 − pk 1 − fk (dg )

Note that the pattern specific predictive density is
fk (dg ) =

r(k)
Y

f (dg,Si,k ),

i=1

where f (dg,Si,k ) is the density for the data indexed by subset Si,k . If measurements
which share a common mean µg are allowed to arise from an observation component,
fobs (·|µg ), and µg arises from a general distribution for the entire genome, π(µg ), then
the predictive density of dg is

Z
f (dg,Si,k ) =


Y



fobs (dg,s |µg ) π(µg )dµg .

s∈Si,k

This posterior predictive density can be used to identify genes with differential expression in at least one condition, to order genes by expression within a condition, or
to classify genes into distinct classes.
The SAM, ANOVA, and Empirical Bayes methods perform well on static microarray data. These methods have been proven robust in other applications; however,
the question of whether they can be adapted to the multiple comparisons aspect of
microarray data is still unanswered.
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1.2.3.4

Multiple Comparisons

When determining significance of multiple comparisons, the family-wise error
rate—the probability of making one or more Type I errors in a group of comparisons—
is typically used in place of α. When analyzing microarray data, commonly used
controls of the family-wise error rate are generally too conservative.

Benjamini

and Hochberg (1995) suggest controlling an alternative rate, the false discovery rate
(FDR), which offers some distinct advantages over traditional methods. The FDR is
defined as the rate of falsely rejected hypotheses. In Table 1.2, m total hypotheses
are partitioned by whether they are null and whether they have been declared significant. The number of null, non-significant hypotheses is U ; the number of null,
significant hypotheses is V ; the number of non-null, significant hypotheses is T ; and
the number of non-null, non-significant hypotheses is S. FDR can be described as
V /R, where R is the total number of significant hypotheses. To determine significant
p-values using the FDR controlling procedure, begin by ordering the p-values such
that p(1) ≤ p(2) ≤ . . . ≤ p(m) . Compute

i
q∗
m

where k is the largest i for which p(i) ≤

i
q∗.
m

for each p(i) . Reject all p(i) where i ≤ k

Table 1.2: Number of errors committed when testing m null hypotheses. The number of true null hypotheses is represented by m0 . The proportion of falsely rejected
hypotheses is V /R.

True null hypotheses
Non-true null hypotheses

Declared
non-significant
U
T
m-R

Declared
significant
V
S
R

Total
m0
m-m0
m

There are several concerns with family-wise error rate control that are resolved
by FDR methods. First, many multiple-comparison procedures assume that the test
statistics are multivariate normal; when this assumption cannot be made, these pro-
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cedures fall short. The FDR does not require multivariate normal test statistics and
therefore can be used no matter the test statistic’s distribution. Second, family-wise
error rate control typically has less power than single comparisons made at the same
level. Though FDR also has less power than single comparisons, it has more power
than family-wise error rate methods. Third, family-wise error rates control the probability of making at least one error. In cases of large numbers of hypotheses, this may
be too stringent of a control. For instance, when testing 1000 hypotheses, one may
be willing to accept more than one falsely rejected hypothesis. Ten falsely rejected
hypotheses are still reasonable and will allow greater power than a more stringent
cut-off. In microarray studies, there is little concern over rejecting a few true null
hypotheses. Not only does microarray data analysis involve thousands of comparisons, but researchers are more willing to make false discoveries since microarrays are
almost always used as a screening device.
There are some interesting comparisons between FDR and family-wise error
rate methods relating to power. FDR controlling procedures uniformly have more
power than other methods. It is important to note that all methods have a decrease
in power as the number of hypotheses increases; however, FDR methods see less of a
decrease in power than other methods.
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2. REVIEW OF METHODS

Though a fairly recent development, microarrays are quickly becoming a widely
used tool in gene analysis. Only slightly fewer than the number of labs using microarrays today is the number of methods to analyze microarray data. The more specific
area of longitudinal microarray data is no different. As of yet, there is no determined
“best” method when it comes to longitudinal microarray data, but there are plenty
of ideas that claim to have good properties and valid results. Some use traditional
statistical ideas such as least squares and maximum likelihood estimates, others take
advantage of more modern approaches like empirical Bayes and hidden Markov models. A comparison of these techniques is needed to evaluate the effectiveness and
efficiency of each method.

2.1

A Modified F -statistic
Storey et al. (2005) propose a modification of existing methods, specifically

spline-based methods, to approach the time course problem. This method is applied
to two recent studies. The method developed by Storey et al. has variations to
fit two different types of time course data: comparisons within a single group and
comparisons between two or more groups. The goal of the method is to identify
patterns over time within a single group or differentially expressed genes over time
between groups. This method fits two models, one under the null hypothesis of
no differential expression over time among groups and one under the alternative
hypothesis of differential expression over time among groups. Figure 2.1 displays
these two models. The null hypothesis treats all data as one group and finds the
“best” fit over time (solid line). The alternative model divides the data into groups
(in this case, drug and placebo) and fits a model for each group (dotted lines). Each
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Figure 2.1: Null and alternative models fit to endotoxin data. × represents treated
individuals and ◦ represents controls. The solid line is the null model fit to all data;
the dotted lines are the alternative models fit to the treated group and the control
group.

A statistic is proposed, similar to the traditional F statistic, and is constructed
(for the i-th gene) as
Fi =

SSi0 − SSi1
,
SSi1

where SSi0 is the sum of squared errors from the null model and SSi1 is the sum of
squared errors from the alternative model. As this statistic does not follow an exact
F distribution, the distribution of this statistic is found using bootstrap re-sampling
techniques. Residuals from the alternative model are re-sampled and added to fitted
values under the null model to simulate the case of no differential expression.
Fi statistics are calculated using the formula above and the null simulated
data. From these statistics the null distribution of Fi can be estimated. P -values
are computed for each gene by finding the proportion of simulated null Fi statistics
more extreme than the observed Fi statistic. Significant genes are determined by
controlling the FDR (see section 1.2.3.4).
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2.2

A Dependent Correlation Matrix
With typical longitudinal data, the key to accounting for time in the analysis

is a dependent correlation matrix. Time course data cannot be assumed to be independent; in fact, it is almost always strongly correlated due to time dependence. At
least two authors incorporated this correlation matrix into their proposed methods.
Luan and Li (2004) use a first-order auto-regressive correlation matrix to describe the
error term in their model:

2

ni −1

ρ ρ ... ρ
 1

 ρ
1 ρ . . . ρni −2



..
Σ = σ2 
.


 ρni −2 . . . ρ 1
ρ


ρni −1 . . . ρ2 ρ
1








,






where ni is the number of data points for the i -th gene and ρ is the first-order
correlation between two time points. This correlation matrix assumes that time
points near each other are highly correlated and that correlation decreases as the
distance between time points increases. This analysis controls the false discovery
rate (FDR) to decide which genes are periodically expressed. Interestingly, the FDR
procedure does not involve any form of standard error; therefore, the autoregressive
correlation does not seem to affect the decision.
Guo et al. (2003) also used a correlation matrix in their analysis to account
for dependence in the data. As shown in both simulated data and sample data sets,
misclassifying data as independent potentially leads to invalid inference. Unlike Luan
and Li, Guo et al. do not give a specific correlation matrix to use, leaving it up
to the researcher to choose. Despite the authors’ insistence that methods assuming
independence cannot be applied to longitudinal data, they use an independenceworking correlation structure in their example “for simplicity.”
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2.3

A Robust Wald Statistic
As one of the pioneer papers in analyzing longitudinal gene expression data, the

methods used by Guo et al. approach longitudinal gene expression analysis using a
basic generalization of simple techniques. The paper proposes a robust Wald statistic
for the ith gene of the form
W (i) = [Lβ̂(i)]0 [LV̂S (i)L0 ]−1 [Lβ̂(i)],
where V̂S (i) takes a working correlation matrix into account. The statistic is considered “robust” because it uses permutation methods to create an accurate sampling
distribution of the test statistic even though the sample size is small.
Also defined in the paper is the gene-specific score,
w(i) = [Lβ̂(i)]0 [LV̂S L0 + λw Ir×r ]−1 [Lβ̂(i)],
which incorporates a small value in the denominator to solve singularity and normalization problems.

2.4

Guide Genes
Luan and Li propose a method using “guide genes,” genes known to be peri-

odically regulated. These include genes involved in cell cycle regulation as well as
those involved in circadian rhythmic regulation—rhythms expressed over a 24-hour
time period. From these genes, a general function for all cyclically expressed genes
can be estimated. The functions of genes with unknown regulation patterns can then
be compared to this “standard” function and, using likelihood ratio tests, determined
to be of the same cyclic pattern or not.
The idea behind this model-based approach begins by estimating the model for
the guide genes using a cubic B-spline-based periodic function. The model for all
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genes (guide and otherwise) assumes
Yij = µi + βi f (tij − τi ) + ij
for gene i and observation j where µi is the mean gene expression level for the ith gene,
f is the common function of the guide genes, tij is the time when the ij th sample was
taken, and βi and τi are location and scale parameters for the ith gene. The model
for the unknown genes is assumed to be computed in a similar fashion, although the
paper is not clear on this point. To determine whether the unknown genes follow the
same pattern as the guide genes, the test βi = 0 is performed. If βi = 0, the model
becomes
Yij = µi + ij .
Since this model does not include any time effect, it is equivalently testing the periodicity of each gene.

2.5

Mixture Analysis
Although genes are often classified by their function, this does not necessarily

mean that functionally similar genes, or classes, follow the same expression patterns.
Gui and Li (2003) introduce a method to distinguish between mixtures of expression
patterns within a classification group. The method, mixture functional discriminant
analysis (MFDA), uses B-splines and the EM algorithm to estimate a likelihood for
each gene, then evokes maximum likelihood to determine which subclass the gene lies
in.
To demonstrate the accuracy of MFDA, three classes are simulated, two of
which are single classes and one of which is a mixture of 4 subclasses. MFDA is
compared to three other methods using this simulated data set. MFDA appears to
outperform the others (MDA, FLDA, and LDA). A real data set of yeast cells is
also analyzed using these four methods. Reserving one-third of the genes to use for
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validation purposes, the misclassification rates are compared for the methods. In
general, MFDA again performs best.

2.6

Hidden Markov Models
Identifying differential expression over time is a daunting task with microarray

experiments. Many researchers will attempt to treat each time point as independent of one another and use traditional approaches for determining significance, but
time course data exhibits dependence due to time which violates the independence
assumption. Yuan et al. (2003) proposed a method using Markov chains to account
for this dependence and determine the expression patterns over time in microarray
data.
The method begins by identifying patterns, or states, of interest. For example,
if there are three biological conditions, there are five possible expression states: µ1 =
µ2 = µ3 or µ1 = µ2 6= µ3 or µ1 6= µ2 = µ3 and so on. The goal is to estimate the
most probable set of states over time. To estimate the probability of each state, the
expression patterns are assumed to follow a Markov chain. That is, the probability
of a given state j at time t is πj (t) = P (st = j). The initial probability distribution
is defined as π(1) = (π1 (1), . . . , πJ (1)). The transition matrices for the Markov chain

are A(t) = ai|j (t) , where ai|j (t) = P (st+1 = i|st = j). Also necessary to compute
the most probable set of states is the conditional distribution xt |st = i ∼ fit (xt ).
The Baum-Welch algorithm is used to estimate the initial probability distribution of
states, the transition matrices, and the conditional distribution of expression level
given a specific expression pattern. These estimates are then used in the Verbiti
algorithm to determine the most probable set of expression patterns over time.
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2.7

Method Comparison and Evaluation
One difficulty in comparing the different analysis methods available for time

course microarray experiments is that each method does not necessarily produce the
same type of results. That is, the hypotheses being tested vary among the different
methods. For example, the guide genes method proposed by Luan and Li (2004)
explains which genes have periodic expression similar to that of the guide genes. In
contrast, the method proposed by Storey et al. (2005) seeks to determine whether each
gene shows an effect over time. Additionally, the method used by Yuan et al.’s (2003)
determines the most probable set of expression patterns over time. Consequently, it
is problematic to compare all of these methods simply on the basis of their results.
Because each method is specific to certain types of data, each method must be
evaluated individually. A simulation can provide method-specific data to investigate
a method’s power and specificity. Though evaluating each of the above methods
through simulation-based approaches is beyond the scope of this paper, the method
used by Storey et al. will be used as an example and model for future methods.
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3. STOREY METHOD

Gene expression analyses are difficult to evaluate because the true distribution
of genetic data is extremely complicated. Estimates of gene expression data are
overly simplified and skeptical at best. Consequently, many methods exist to detect
significance in gene expression data, but there is no gold standard to decide which
method detects the type of significance a researcher is interested in.
Rather than attempting to simulate a set of genes with complex dependencies
and unknown distributions, a simulation could borrow information from existing data
to generate a gene within a reasonable range following plausible patterns. The method
can then be evaluated by appending this new gene to the existing data set and
exploring the method’s sensitivity to this new gene.
Of the methods summarized in the previous chapter, the Storey method lends
itself to investigating the simulation-based approach to gene expression analyses.
Storey et al. provide well-documented code along with their method, allowing it to
be easily recreated and modified for simulation purposes. Also, this method is innovative, yet traditional and relatively simple, appeasing most audiences. This method
will be discussed in more detail in the following sections.

3.1

Motivating Experiment and Objective
Two studies motivate and illustrate the method used by Storey et al. The

first study examines the mechanisms behind endotoxin response. Endotoxin contains
lipopolysaccharide, a macromolecule found in the cell membrane of certain bacteria.
In humans, small amounts of endotoxins cause rapid physiological changes, particularly a temperature increase. Endotoxins are useful in immune response studies
because of their non-toxic nature; although endotoxins illicit an immediate immune
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response, they do not harm their host. The endotoxin study involved eight subjects.
Each was given either endotoxin or a placebo (four in each group). At six time points,
one before treatment and five after treatment, blood was collected from each subject.
The time points after treatment were 2, 4, 6, 9, and 24 hours following treatment.
The second study differs from the first in that the observations are independent.
Human subjects ranging from 24 to 92 years old were used to study the effect of age
on the kidneys. Kidney tissue was extracted from each subject for the study. The goal
of this investigation was to determine which, if any, genes show differential expression
over time in kidney tissue. Because following a group of subjects over 50 years is
impractical in this case, the independent sampling scheme used here is appropriate.
Both motivating studies examine differential gene expression over time. In
the first study, a static experiment would partially reveal which genes are affected
by endotoxin, but would fail in identifying genes affected at different stages following
endotoxin introduction. A time course experiment is necessary to identify which genes
show differential expression. In the kidney study, one may be tempted to treat the
data as static because the observations are independent; however, current methods
for static data are designed for unordered categorical conditions. Time is neither
unordered nor categorical; thus, a time course method is necessary for the kidney
data as well. This design also proves advantageous when the data is not balanced or
only one observation is available for each time point. Whereas a method for static
data requires imputing missing data or arbitrary measures to compensate for these
conditions, this method borrows information inherent in the time variable to avoid
unnecessary assumptions.

3.2

Detecting Differential Gene Expression
The method developed by Storey et al. has variations to fit two different types

of time course data: comparisons within a single group and comparisons between two
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or more groups. For the purpose of this thesis, the method will be described as it
applies to the endotoxin data, which is a comparison between two groups. The goal of
the endotoxin study is to identify differentially expressed genes over time between the
endotoxin group and the placebo group. That is, the investigators want to identify
which genes show significantly different patterns over time when exposed to endotoxin
versus unexposed to endotoxin.
This method fits two models, one under the null hypothesis of no differential
expression over time among the groups and one under the alternative hypothesis of
differential expression over time among the groups. Figure 2.1 displays these two
models. The null hypothesis treats all data as one group and finds the “best” fit over
time (solid line). The alternative model divides the data by endotoxin-treated and
placebo and fits a model for each group (dotted lines). These models are fitted using
a natural cubic spline.1
A statistic is proposed, similar to the traditional F statistic, and is constructed
(for the i-th gene) as
Fi =

SSi0 − SSi1
,
SSi1

where SSi0 is the sum of squared errors from the null model and SSi1 is the sum of
squared errors from the alternative model. In a traditional F statistic, the random
errors are assumed to follow a Normal deviation. The random errors in the above
statistic do not follow this assumption; therefore, the statistic does not follow an exact
F distribution. The distribution of this statistic is found using bootstrap re-sampling
techniques. Residuals from the alternative model are re-sampled and added to fitted
values under the null model to simulate the case of no differential expression. The
sampled residuals come from the alternative model because the alternative model
makes no assumptions concerning whether the null or alternative hypotheses are
true. These residuals are added to the null model fit because the class of null models
1

Another option is to use a polynomial basis, which proved effective in both studies, but is less
flexible and more assumptive than the natural cubic spline (Storey et al. 2005).
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represents a true null hypothesis.
Fi statistics are calculated using the formula above and the null simulated
data. From these statistics the null distribution of Fi can be estimated. P -values
are computed for each gene by finding the proportion of simulated null F statistics
more extreme than the observed Fi statistic. Significant genes are determined by
controlling the FDR (see section 1.2.3.4).

3.2.1

Method Details
The endotoxin data that motivated this method was used to recreate and in-

vestigate facets of this method. Before fitting a natural cubic spline to the data (as
the method dictates for both null and alternative models), knots must be determined.
Knots are selected as equally spaced quantiles of the time vector. The number of knots
is predetermined by the dimension of the basis for the spline, or p. In the EDGE
software documentation, p is chosen as one less than the number of time points if the
number of time points is less than four, and p is selected using a method involving
singular value decomposition if there are four or more time points. The idea behind
this method is to select the value of p that enables curves to be fitted to the top
eigen-genes.
Once the dimension of the basis, p, is determined, the population average time
curve for gene i can be written as

µt (t) = βi0 + βi1 s1 (t) + βi2 s2 (t) + . . . + βip sp (t),
where s(t) = [s1 (t), s2 (t), . . . , sp (t)]0 is the basis function and β i = [βi0 , βi1 , . . . , βip ]0 is
a vector of gene-specific parameters. Because a cubic spline is used, si (t) = ai + bi t +
ci t2 +di t3 . To compute ai , bi , ci and di for each knot, 4p constraints must be used. 4p−2
constraints are allocated by setting the function and first and second derivatives of the
function equal to the neighboring function (or first or second derivative, respectively)
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at each knot. The final two constraints require the second derivatives of the first node
and the last node to be zero.
Different techniques are used to fit the model depending on the type of data.
Independent data require a different method than longitudinal data, and fitting an
intercept requires a different method than omitting the intercept. Longitudinal data
with an intercept cannot be fitted explicitly because the individual random effect is
unobserved. Therefore, an EM algorithm estimates the individual random effect, after
which the other parameters can be computed. A more direct approach is available if
the intercept is not of interest in the analysis. If this is the case, the observations can
be centered for each individual, removing the unobserved individual random effect
from the model. This individual-centered method utilizes least squares to fit the
parameters of interest.

Figure 3.1: Distribution of p-values for endotoxin data. The distribution of p-values
is strongly right-skewed in this case, indicating that most p-values are small.

The p-values have a strongly right skewed distribution (see Figure 3.1). At a
cut-off of 0.05, 487 genes (over half of the genes) are called significant. The proportion
of true null hypotheses, π0 , is estimated to be 0.1397. Figure 2.1 displays null and
alternative models fitted to a significant gene. At high significance, the null and alter-
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native models are obviously distinct and significance is apparent. At non-significance,
the models overlap, often indicating that the null model is just as appropriate for the
gene as the alternative models. At either extreme, a graphical display of the data and
the models fitted to the data is enough to determine significance. When a gene falls in
the middle (neither highly significant nor highly non-significant), a more quantitative
cut-off is necessary.
The R code for all implementation is included in Appendix A. The functions get.pvalues and mat.sq are borrowed from the EDGE software developed
by Alan Dabney, Jeffrey Leek, Eva Monsen, and John Storey. The remainder of the
storey.sim function is modeled after components of the EDGE software. The other
functions are original work of the author.
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4. SIMULATION STUDY

A simple, computationally inexpensive simulation can often provide validation
of a method much more easily and quickly than a mathematical proof. Simulations can also offer interesting insights into particular aspects of an analysis method.
Though typically less general than a proof, the specificity of simulations can sometimes be an advantage. This simulation validates the Storey method by simulating
data based on the features and patterns found in the endotoxin data, thus providing
a researcher using the Storey method on the endotoxin data with very detailed information regarding which types of genes will be identified as significant. If the type of
pattern the researcher hopes to identify is not picked up by this method, this simulation will identify this shortcoming before time and resources are spent on further
investigation. These simulation results can only be directly applied to this particular
combination of method and data; however, this simulation approach can be applied
to any study.
The first task of any simulation is deciding how to generate data. Once the
specifics for simulating data are established, features of the data can be manipulated
to study the method. Finally, the results reveal important aspects of the method’s
limits of detection. Each of these steps are performed on the endotoxin data from
Storey et al.

4.1

Simulating Gene Expression Data
Simulating gene expression data is not trivial. Biological systems are known to

be complex and individual genes are far from independent. Thus, the first task in
a gene expression simulation study is simulating feasible data. Although potentially
oversimplified, simulated gene expression data allows manipulation of characteristics
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of the data in order to verify a method’s power.
To imitate the endotoxin data, one could simulate separate null and alternative
data to correspond to control and treated arrays, respectively. The null data would
have a constant effect over time whereas the alternative data would have a variety
of effects over time. For instance, one alternative gene could have a very defined
deviance from the null levels while another alternative gene could be just slightly
shifted from the null pattern. A third alternative gene could have the same overall
level as the null genes, but a different effect over time. The possibilities are endless,
but they may not all be reasonable. It may not be realistic to see such a combination
of patterns in a single data set. The more genetic variation induced on a simulated
data set, the more uncertainty generated as to whether the data set is plausible.
An alternative to generating an entire set of gene expression data is to manipulate an existing data set. For instance, the endotoxin data could be centered such that
the error introduced by each individual is subtracted out. Then, random error could
be added back to the centered data to create a new, “random” data set incorporating
all the complicated dependencies in real gene expression data. This idea is similar
to the method described in Chapter 3 used to estimate the null distribution of the
F -statistic.
A third option is to leave the existing data exactly as it is and add a single
simulated gene to the current data set. This approach is similar to the spike-in
approach, originally developed to validate expression level measurements on an array.
Spike-in genes are genes which are added to but not naturally found in the sample.
For example, arabidopsis (a flowering plant) genes may be “spiked-in” to a sample of
rat RNA. The spiked transcripts are added in known quantities, providing a standard
to compare to the other spots on the array. Similarly, adding a single simulated gene
with known features to an existing data set allows a comparison of the significance
of other genes to this known gene. This would allow investigation of the method’s

45

sensitivity and power by manipulating the single gene to exhibit various properties
(significant, nonsignificant, linear time effect, sinusoidal time effect, magnitude of
differential expression, etc.).
The third option is the approach chosen to perform this simulation study; it is
straightforward, simplistic and makes the fewest alterations to the existing data. For
purposes of this study, the expression levels for gene i and individual j are assumed
to follow a normal distribution with mean µ and have a spatial power correlation
structure, as follows:
yij = N (µj , Σ),

1







2
Σ=σ 







ρ

2

ρ

4

ρ

6

9

ρ

24

ρ

ρ2

1

ρ2

ρ4

ρ7

ρ22

ρ4

ρ2

1

ρ2

ρ5

ρ20

ρ6

ρ4

ρ2

1

ρ3

ρ18

ρ9

ρ7

ρ5

ρ3

1

ρ15

ρ24 ρ22 ρ20 ρ18 ρ15



1








.








The covariance between time ti and tj is equal to ρ raised to the distance (in hours)
between the two time points.
Each gene has 46 observations—eight individuals each with samples taken at
six time points, except for one individual who only has samples taken at four time
points. To obtain the 46 expression values for a simulated gene, each individual’s six
(or four) time points will be computed separately using the distribution above, then
concatenated to form a 1 × 46 vector to be appended to the existing data set, which
currently has dimensions of 800 × 46.
The mean vector used to simulate each individual’s six (or four) time points
depends on whether the individual is from the control group or the treated group. If
the individual is from the control group, µ will be estimated using only the control
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arrays from the original data set. If the individual is from the treated group, µ will
be estimated using only the treated arrays from the original data set. The methods
used to estimate these µ values will be discussed in Section 4.2.1.
To estimate ρ, the correlation matrix for each gene was computed. (Individual
six is missing two time points and therefore was not included in this estimation.)
For computational purposes, only the correlation matrices with no negative elements
were included.1 By excluding correlation matrices with negative elements, 375 genes
of the total 800 genes were used to estimate ρ. Each of these 375 matrices were
passed through a function that raised each element to the inverse power as exhibited
in the correlation structure above. For instance, the second element of the first row
of each estimated correlation matrix was raised to the

1
2

power. The average of these

transformed off-diagonal elements was retained as the ρ estimate for that gene. These
375 estimates of ρ have a slightly left-skewed distribution (see Figure 4.1); however,
the mean and median are very close (mean = 0.692, median = 0.704), so either could
be used with similar results. The median was chosen for use in this simulation.
To estimate the variance (σ 2 ) to be used to simulate a new gene, the variance
at each time point for each gene was computed. This distribution is strongly rightskewed (see Figure 4.2); therefore, the median will be used instead of the mean. The
median of this distribution is 262,275 squared expression units.

4.2

Varying Features of the Data
Four features of the data are evaluated in this simulation: µ, ρ, σ 2 , and the

magnitude of difference between control and treated array vectors. For each selected
combination of these four parameters, 1000 simulations were conducted. That is,
1

The presence of negative elements in the sample correlation matrices raises concern about the
chosen correlation structure, but only 13% of the off-diagonal elements of the sample correlation
matrices were less than 0, and the median of these negative elements is -0.23. Therefore, for the
purposes of this study, the negative correlation will be assumed to be due to random noise and only
positive values of ρ will be considered.
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Figure 4.1: A histogram of estimates of ρ. The distribution is slightly left-skewed,
but the mean and the median are close in value.

1000 new genes were simulated and concatenated one at a time to the existing 800
genes. The Storey method was used to assign each gene a p-value and q-value. As
discussed earlier, p-values are too conservative for microarray analyses; q-values are
designed such that the cut-off is chosen after the simulation is conducted, making
them an inconsistent evaluator for multiple simulations. The measurement chosen to
evaluate and compare each simulation was the number of times the new gene was
ranked in the top 100 out of all 801 genes. This is the value reported in the following
figures.

4.2.1

Choice of µ
The choice of mean vector to use as the basis for simulating a new gene can

greatly affect the results. There are many ways to estimate a reasonable mean vector
for these two groups. Three methods for choosing µ are used in this simulation.
The first method can be used to simulate null genes. These are genes that have
no statistically significant difference between treated arrays and control arrays. To
ensure these genes are truly null, both the control and treated individuals will come
from the same mean vector. This method uses all 800 genes, but only the control
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Figure 4.2: A histogram of estimates of the variance. The distribution is strongly
right skewed, therefore the median will be used as the estimate of variance.

arrays, to compute the mean value for each time point. This mean vector will be used
for all individuals, whether control or treated. Figure 4.3 plot A shows control (red
line) and treated (blue line) array vectors over time. The second method is similar,
but only uses non-significant genes (q ≥ 0.1) and control arrays to compute the mean
value at each time point. Figure 4.3 plot B shows these vectors.
Each of these methods could be slightly modified to produce alternative genes—
genes with significantly different patterns for control arrays and treatment arrays.
The first method would use all the data but would compute two values at each time
point—the mean of control arrays and the mean of treated arrays—thus allowing for
differential expression. The second method would likewise compute two means for
each time point, but only the means of significantly expressed genes. Figure 4.3 plot
D shows the control and treated array vectors produced using this method. As most
genes in the data set are significant, these two alternative methods produce virtually
identical results. Therefore, only the second method was used in the simulation.
The third method appeals to the idea of gene groupings. Within the 800 genes
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in the original data set, there may be several genes that follow the same general trend.
A realistic simulated gene might also follow this pattern. To identify such a group, the
genes were grouped into clusters using hierarchical clustering methods. Plots of the
largest clusters reveal two main patterns: a non-substantially differentially expressed
pattern and a substantially differentially expressed pattern. The mean vector from
the first pattern was used to simulate null genes (see Figure 4.3 plot C), and the mean
vector from the second pattern was used to simulate alternative genes (see Figure 4.3
plot E).
All five sets of vectors (three null vectors and two alternative vectors) are shown
in Figure 4.3. Note that the first two null vectors (plots A and B) have identical
vectors for control arrays and treated arrays. In plot C, the vectors are estimated
using a non-differentially expressed cluster. Unlike plots A and B, the vectors for
control and treated arrays are not identical, but compared to the range of expression
level they are similar enough to be the basis for a null gene. Plot D show the mean
vectors for an alternative gene estimated using only significant data. The difference
between control and treated arrays in plot D is less distinct than in plot E, but will
begin to reveal the method’s sensitivity.
Power curves from simulated genes using these vectors are shown in Figure 4.4.2
The data used to construct this figure are found in Tables B.3, B.4, and B.5. The
results for null genes appear to be the same regardless of which method is used to
simulate the gene. Very few genes are detected when the control and treated array
values are similar. The mean expression level does not seem to matter as long as the
mean vector is essentially the same for control and treated arrays.
The genes simulated using Figure 4.3 plot E are nearly always ranked in the
top 100 genes (proportions between .975 and .995). This seems intuitive, as the diff2

The y-axis scale changes in Figure 4.4 are designed to allow the reader to see subtle changes
in the data. Were all five plots to be put on the same scale as plot D, plots A-C would appear as a
straight line at a proportion of 0, with a slight upward trend as ρ increases and plot E would be a
straight line at a proportion of 0.99.
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erence between the control and treated arrays is very large. It is interesting to note
that although the contrast between the two types of significant genes is pronounced
(Figure 4.3 plots D and E), the method still detects significance in the less extreme
genes (Figure 4.4 plot D). Section 4.2.4 addresses the effect on significance as the range
between these two extremes changes. Sections 4.2.2 and 4.2.3 discuss the effects of
changing ρ and σ 2 , respectively.

4.2.2

The Effect of ρ
Because the endotoxin data was collected over time, it was necessary to intro-

duce correlation into the simulated genes. A spatial power correlation structure was
used to simulate this correlation, as shown in Chapter 3. The data suggested using
ρ = 0.7 to create the correlation matrix; however, high correlation can inflate significance. One aspect of this simulation investigated the effect of ρ on power. Four values
of ρ were used: 0, 0.5, 0.7, and 0.9. These values were chosen based on the value
suggested by the data and other reasonable quantiles (ρ = 0 investigates independent
data, ρ = 0.5 investigates moderately correlated data, and ρ = 0.9 investigates highly
correlated data).
Figure 4.4 shows the results of varying ρ. As expected, increasing correlation
also increases significance. Interestingly, this effect is different depending on the choice
of µ. In plots A and B, even null and alternative arrays generated from exactly the
same vectors can become significant if the correlation is high enough. Note that even
at extreme values of ρ, simulated genes are only ranked in the top 100 between 2%
and 5% of the time. In all the plots, the number of correctly identified significant
genes increases as ρ increases; however, this effect is most easily seen in plot D.
In plot E of Figure 4.4, the proportion of significant genes is not monotonically
increasing as in the other plots. The pattern seen is most likely due to the fact
that this type of simulated gene is almost always significant; the proportion of top
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100 ranked genes can’t grow much larger. Fluctuations from a straight or possibly
slightly increasing line are due to error. If this plot were on the same scale as plot D
(spanning a range of 0 to 1), all three lines would lie on top of each other, appearing
straight to the casual eye.

4.2.3

The Effect of σ 2
The strength of the Storey method lies in detecting significant differences in

trends between groups. Two groups may have very different mean vectors, but could
appear to be random noise if enough variation is introduced. This simulation looks
at the effect of variation (σ 2 ) on power; specifically, how large σ 2 can be before
differentially expressed genes appear insignificant. Three values of σ 2 were used for
this simulation: 25,000, 250,000, and 2,500,000. The middle value was suggested by
the data and the other two encompass a reasonable range for study.
In Figure 4.4, the effect of σ 2 appears to agree with intuition: as σ 2 increases,
significance decreases. As variation increases, the degree of separation between the
control and treated arrays lessens, thereby requiring greater separation between array
types to detect significance. The effect of changing σ 2 does not seem to affect the null
genes because all arrays in the null genes come from the same or nearly same mean
vector. As there is no or little difference between control and treated arrays in null
genes, small variation in the data will be detected as non-significant just as often as
large variation in the data will be detected as significant. As discussed above, high
correlation will induce significant results, but only a small proportion of the time.
The effect of changing variance is most easily seen in plot D. At large variance
levels, the gene is almost never ranked in the top 100. In fact, this gene appears very
much like the three null plots (plots A–C) as seen by the dotted lines. On the contrary,
at small variance levels this gene appears just as the alternative genes generated in
plot E. This particular mean vector could be used to generate a highly significant
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Figure 4.5: First attenuation simulation. The vectors used to simulate alternative
genes displaying attenuation of distinctness (top left). The black line is the set of
gene expression means used for the control arrays regardless of alternative vector
used. The colored lines are the six sets of gene expression means used to simulate
treatment arrays. The power curves showing effect of attenuating difference between
control and treated arrays (top right). The farther the distance between the control
and treated array gene expression values, the more often the simulated gene is ranked
in the top 100 out of all 801 genes. The bottom center plot magnifies the top portion
of the top right plot.
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Figure 4.6: Boxplots of ranked genes from first attenuation simulation. Each boxplot
displays the distribution of the ranking of 1000 simulated genes. Plot A represents
simulated genes from the original cluster (Figure 4.3 plot E, or Figure 4.5 blue lines).
Plots B–F display the boxplots of increasingly attenuated treated vectors, corresponding to the colored lines of Figure 4.5.
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gene or a highly non-significant gene simply by altering the variance. At the middle
value of σ 2 , the effect of ρ is most easily seen.

4.2.4

Attenuation of Difference Between Control and Treated Arrays
The final feature of interest in simulated data is the difference between the

control and treated array vectors. In Figure 4.3, the alternative gene simulated using
clustered data (plot E) reveals a large difference in range between the red control
vector and the blue treated vector. Instinctively, one can identify this as a significant
gene. If the treated vector were not so substantially different from the control vector,
this significance would become less obvious. As the treated vector approaches the
control vector, the gene would become non-significant. One aspect of this simulation
investigates how power changes as the difference between control and treated array
vectors attenuates.
Figure 4.5 (top left) shows six treated array vectors. The blue vector is the
original treated array vector for an alternative gene using clustered data, as in Figure 4.3. The other colored vectors have the same overall pattern, but the effect of
the drug has been lessened in each vector. The black vector is the original null vector
and is used for each simulation regardless of alternative vector used. Figure 4.5 (top
right) displays the results of simulating genes based on these six different treated
array vectors. The data used to construct this plot are found in Table B.1. The three
alternative vectors with the largest distance to the control vector (blue, purple, and
turquoise lines) are all highly significant, regardless of the value of ρ. As the distance
between the control and treated vectors decreases to approximately 2000 expression
units, the significance of the simulated genes drops. At ρ = 0.7, the proportion of
simulated genes drops from 0.7 to 0.4 to 0.15 while the effect of the treated arrays is
slightly attenuating.
Figure 4.6 displays boxplots of the rankings of the 1000 simulated genes from
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this attenuation simulation. The data used to construct this plot are found in Table
B.6. Plot A represents the original alternative vector, while plots B–F represent the
five attenuating vectors in Figure 4.5, from largest difference to the control vector to
least difference. Again, we note that the first three vectors are all highly significant
(median ranking is approximately 100). Interestingly, we can see in these boxplots
that the third vector (plot C) is substantially more right-skewed than the first two
vectors (plots A and B). In plots D–F we again note the effect of ρ as well as the
decreasing significance as the alternative vector approaches the control vector; however, these plots also reveal how right-skewed these distributions are. This simulation
identifies what magnitude of difference between control and treated arrays is needed
before the method detects the gene as significant.
Figures 4.5 and 4.6 reveal information about one type of pattern seen in the
endotoxin data set. Other patterns may also have interest to the researcher. For instance, Figure 2.1 shows one of the most highly significant genes in the data set. This
gene has the opposite trend as the gene pattern in the first attenuation simulation.
Instead of having decreased transcription levels following treatment, this gene has
increased levels following treatment. One may be interested in how the significance
levels change as this gene’s effect is attenuated. Another attenuation simulation was
conducted using this gene as a basis for the mean vectors. Figure 4.7 (top left) shows
the original control (black line) and treated array (blue line) vectors as well as three
other treated array vectors used to simulate genes.
Figure 4.7 (top right) displays the results of this attenuation. The data used to
construct this plot are found in Table B.2. The first two treated arrays, the blue and
green lines, nearly always produce genes ranked in the top 100. The vector represented
by the orange line shows a dramatic drop to 30% of the genes being ranked in the top
100 when ρ = 0.7, while the vector represented by the red line has nearly no genes
ranked in the top 100 when ρ = 0.7.
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Figure 4.7: Second attenuation simulation. The vectors used to simulate alternative
genes displaying attenuation of distinctness (top left). The black line is the set of
gene expression means used for the control arrays regardless of alternative vector
used. The colored lines are the four sets of gene expression means used to simulate
treatment arrays. The power curves showing effect of attenuating difference between
control and treated arrays (top right). The farther the distance between the control
and treated array gene expression values, the more often the simulated gene is ranked
in the top 100 out of all 801 genes. The bottom center plot magnifies the top portion
of the top right plot.

59

Figure 4.8 shows the boxplots corresponding to the four treated vectors in
Figure 4.7. The data used to construct this plot are found in Table B.7. Plot A
corresponds to the original treated vector, plot B corresponds to the green vector,
plot C corresponds to the orange line, and plot D corresponds to the red line. As in
Figure 4.6, we see that as the genes become less significant, the boxplots have longer
tails and wider interquartile ranges.
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Figure 4.8: Boxplots of ranked genes from second attenuation simulation. Each boxplot displays the distribution of the ranking of 1000 simulated genes. Plot A represents
simulated genes from the original gene (Figure 2.1 or Figure 4.7 blue line). Plots B–D
display the boxplots of increasingly attenuated treated vectors, corresponding to the
colored lines of Figure 4.7.
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5. EVALUATING GENE EXPRESSION ANALYSES
THROUGH SIMULATION STUDIES

The results from the Storey method simulation provide insight into the Storey
method, the endotoxin data, and the way the method and data interact. In summary,
the following was found through the simulation.
In the endotoxin data set, the dominating pattern among treated arrays is to
start at normal expression levels, drop to low expression levels immediately following
treatment, and come back to normal expression levels by 24 hours past treatment.
Occasionally, a gene follows the opposite pattern—increase in expression following
treatment, then drop down to normal expression levels soon after. The study shows
the Storey method is very sensitive to this type of differential expression, as it detects differences as small as 2000 gene expression units between control and treated
arrays approximately 70% of the time. The endotoxin data estimated ρ as 0.7 and
σ 2 as approximately 250,000 gene expression units. As ρ increases to 0.9, artificial
significance is seen in null genes; however, at 0.7, the inflation in significance is not
present among null genes. Changing the variance had some slight effects, but these
effects were only detectable when the gene fell in the grey area between significance
and non-significance.
The specificity of these results to the data and method make them of little
interest to a researcher with other data and analysis methods; however, the process
that produced these results is enlightening and generalizable to any research situation. The numerical data produced by microarray experiments is relative to the
details of the experiment. While a surrogate of the quantity of RNA transcripts,
gene expression measurements do not represent an empirical quantity within the cell.
They are merely a surrogate value to provide a level of expression compared to other
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genes. The interpretation of these artificial units is dependent on the type of array
being used, how the arrays were prepared, and the other arrays in the sample. Array
normalization can help make results comparable between slides, but the researcher is
still unsure what “significant” really entails. The end result of a microarray analysis
is a list of genes deemed significant by the method used; however, this information
rarely encompasses everything the researcher is interested in. What types of genes
are being called significant? What patterns are detected by this method? At what
point does a gene fall on the line between significant and non-significant? These are
all questions that can be answered by this simulation study.
The spike-in approach, developed to validate levels on an array, provides the
inspiration for the technique used in this simulation. Spiked genes—genes artificially
added to but not naturally found in the sample—are added in known quantities,
thereby providing a reference for the experimental results. Similarly, this simulationbased approach adds a single gene with known features to an existing data set. By
observing the significance levels of the known gene, the researcher can have a better
idea of what types of genes the method is finding to be significant and to which gene
features the method is most sensitive.
Using the steps outlined by the endotoxin example, one can analyze the consequences of using any analysis methods on any gene expression data. Although this
process may seem tedious and time consuming, the process used for the endotoxin
example can be modified to fit nearly any gene expression analysis. These steps are:
(1) Determine patterns of interest in the data. These patterns may be found by
examining dominant clusters, or they may be chosen by the researcher based
on knowledge from previous studies.
(2) Estimate reasonable parameter values. The endotoxin example used the
study’s data to estimate starting values for parameters such as µ, ρ, and
σ 2 , but one could use historical data to find these values as well.
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(3) Generate a single gene to append to an existing data set. This example assumes that a new gene is normally distributed with a spatial power correlation
structure; however, if another distribution seems better suited to the data,
these parameters can be easily modified.
(4) Analyze the outcome of changing features of the simulated gene. This simulation study investigated the effects of changing µ, ρ, σ 2 , and the difference
between control and treated arrays. The choice of what to manipulate should
be made based on the data type and research question(s).
These steps, modified to fit a particular combination of method and data, will
help a researcher understand what significance involves and how to better interpret
the raw analysis results.
Future research could not only investigate features of the data, but could look
into aspects of the method as well. For instance, this method provided options to
be chosen by the user such as spline type (polynomial or natural cubic), number of
knots, and number of bootstrap iterations. Adjusting these arbitrary measures may
alter the method’s specificity to different gene expression patterns.
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A. SOURCE CODE FOR STOREY ET AL. METHOD

storey.sim <- function(data,B) {
#input data with genes in columns (46 X 800)
y <- data
#load required libraries and functions
library(splines)
library(MASS)
library(qvalue)
rank.matrix <- function(x)
rank<-round(sum(diag(ginv(x)%*%x)))
get.pvalues <- function(lr, lr0, pool=TRUE, zero=FALSE) {
m <- length(lr)
if(pool==TRUE) {
if(is.matrix(lr0)) {lr0 <- as.vector(lr0)}
m0 <- length(lr0)
v <- c(rep(F, m0), rep(T, m))
## Order all "null" and "alternative" statistics together
if(length(lr) < 10000)
ord <- order(c(lr0, lr), decreasing = T)
else
ord <- quick.order(c(lr0, lr), decreasing = T)
## v is a vector containing "TRUE"s at the rankings of the alternative stats
v <- v[ord]
u <- 1:length(v)
w <- 1:m
p <- (u[v==TRUE]-w)/m0
## Reverse the effects of "order()" above
p <- p[rank(-lr)]
## Set any p-value less than 1/m0 to 1/m0
if(!zero) {p <- pmax(p,1/m0)}
} else {
if(is.vector(lr0)) {post.msg("Error: lr0 must be a matrix.",bell=TRUE); return(NULL)}
if(ncol(lr0)==m) {lr0 <- t(lr0)}
if(nrow(lr0)!=m) {post.msg("Error: number rows of lr0 must equal length of lr.",
bell=TRUE); return(NULL)}
lr0 <- (lr0 - matrix(rep(lr,ncol(lr0)),byrow=FALSE,nrow=m)) >= 0
p <- apply(lr0,1,mean)
if(!zero) {p <- pmax(p,1/ncol(lr0))}
}
return(p)
}
mat.sq <- function(X) {
oo <- svd(X)
return(oo$u %*% diag(sqrt(oo$d)) %*% t(oo$v))
}
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#get the data in the right format
individual <- c(5,6,7,8,5,6,7,8,5,7,8,5,7,8,5,6,7,8,5,6,7,8,
1,2,3,4,1,2,3,4,1,2,3,4,1,2,3,4,1,2,3,4,1,2,3,4)
group <- c(rep(1,22),rep(2,24))
time <- c(0,0,0,0,2,2,2,2,4,4,4,6,6,6,9,9,9,9,24,24,24,24,
0,0,0,0,2,2,2,2,4,4,4,4,6,6,6,6,9,9,9,9,24,24,24,24)
#knots are at time 0, 2, 9, 24
knots <- quantile(time,probs=seq(0,1,length=5))[-c(1,5)]
#basis for natural cubic spline
S <- ns(time,knots=knots,intercept=FALSE)
#individual-centered least squares
xx <- S #xx is centered x-matrix around individual means
for(i in 1:max(individual)) {
for(j in 1:ncol(S)) {
xx[individual==i,j] <- S[individual==i,j]-mean(S[individual==i,j])
}
}
##center y-matrix around individual means
yy <- y
for(i in 1:max(individual)) {
for(j in 1:ncol(y)) {
yy[individual==i,j] <- y[individual==i,j]-mean(y[individual==i,j])
}
}
H0 <- xx%*%solve(t(xx)%*%xx)%*%t(xx)
H1 <- 0 * H0
H1[1:22,1:22] <- xx[group==1,]%*%(solve(t(xx[group==1,])%*%xx[group==1,]))
%*%t(xx[group==1,])
H1[23:46,23:46] <- xx[group==2,]%*%solve(t(xx[group==2,])%*%xx[group==2,])
%*%t(xx[group==2,])
#compute fitted values and residual sum of squares for null and alternative models
fit1 <- t(H1%*%yy)
res <- t(yy)-fit1
rss1 = drop((res^2)%*%rep(1,nrow(y)))
fit0 <- t(H0%*%yy)
rss0 = drop(((t(yy)-fit0)^2)%*%rep(1,nrow(y)))
#compute F statistics
FF <- (rss0 - rss1) / rss1
#null distribution of F-stat
gamma<-diag(length(time))
for (j in 1:8)
gamma[individual==j,individual==j] <- gamma[individual==j,individual==j](1/sum(individual==j))
rmv <- rep(0,8)
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for (i in 1:8)
rmv[i] <- which.max(individual==i)
res0 <- res[,-rmv]
gammasq <- mat.sq(gamma[-rmv,-rmv])
gammasq.inv <- solve(gammasq)
res00 <- res0 %*% gammasq.inv
#set.seed(1)
v <- matrix(sample(1:ncol(res00),ncol(res00)*B,replace=T),nrow=B)
inc <- (1:46)[-rmv]
#bootstrap residuals
FF_bootall <- NULL
for (i in 1:B){
res_samp <- matrix(0,ncol(y),46)
res_samp[,inc] <- res00[,v[i,]] %*% gammasq
for (k in 1:8)
res_samp[,rmv[k]] <- -apply(res_samp[,individual==k],1,sum)
yy_boot <- t(fit0+res_samp)
fit1_boot2 <- t(H1%*%yy_boot)
res_boot2 <- t(yy_boot)-fit1_boot2
rss1_boot2 = drop((res_boot2^2)%*%rep(1,nrow(yy_boot)))
fit0_boot2 <- t(H0%*%yy_boot)
rss0_boot2 = drop(((t(yy_boot)-fit0_boot2)^2)%*%rep(1,nrow(yy_boot)))
FF_boot <- (rss0_boot2 - rss1_boot2) / rss1_boot2
FF_bootall <- c(FF_bootall,FF_boot)
}
#to get p-values:
p<-get.pvalues(FF,FF_bootall)
FF0 <- FF_bootall
q<-qvalue(p)
return(FF,FF0,p,q)
}
gene.sim<-function(y,rho,method,gene,var,n,diff=0){
rsub<-rbind(c(1,rho^2,rho^4,rho^6,rho^9,rho^24),
c(rho^2,1,rho^2,rho^4,rho^7,rho^22),
c(rho^4,rho^2,1,rho^2,rho^5,rho^20),
c(rho^6,rho^4,rho^2,1,rho^3,rho^18),
c(rho^9,rho^7,rho^5,rho^3,1,rho^15),
c(rho^24,rho^22,rho^20,rho^18,rho^15,1))
r<-cbind(rsub,matrix(0,6,42))
for (i in 2:8){
j<-(i-1)*6
row<-cbind(matrix(0,6,j),rsub,matrix(0,6,42-j))
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r<-rbind(r,row)
}
r<-r[-c(33,34),-c(33,34)]
sqrtr<-t(chol(r))
clusters <- read.table("3groups.txt")
group <- c(rep(1,22),rep(2,24))
time <- c(0,0,0,0,2,2,2,2,4,4,4,6,6,6,9,9,9,9,24,24,24,24,
0,0,0,0,2,2,2,2,4,4,4,4,6,6,6,6,9,9,9,9,24,24,24,24)

if (method=="part")
{
sigdata<-storey.sim(y,100)
if (gene=="null")
{
nonsig<-which(sigdata$q$qvalues>=0.1)
mu0<-c(rep(mean(y[group==1 & time==0,nonsig]),4),
rep(mean(y[group==1 & time==2,nonsig]),4),
rep(mean(y[group==1 & time==4,nonsig]),4),
rep(mean(y[group==1 & time==6,nonsig]),4),
rep(mean(y[group==1 & time==9,nonsig]),4),
rep(mean(y[group==1 & time==24,nonsig]),4))
mu0<-c(mu0[-c(9,13)],mu0)

sim.p<-NULL
sim.q<-NULL
rank.q<-NULL
for (i in 1:n){
ynew<-mu0+sqrtr%*%(rnorm(46)*sqrt(var))
ysim<-cbind(y,ynew)
simdata<-storey.sim(ysim,100)
sim.p<-c(sim.p,simdata$p[801])
sim.q<-c(sim.q,simdata$q$qvalues[801])
rank.q<-c(rank.q,rank(simdata$q$qvalues)[801])
}
sum.q<-sum(sim.q<=0.1)
sum.p<-sum(sim.p<=0.1)
rank.100<-sum(rank.q<=100)
}
if (gene=="alt")
{
sig<-which(sigdata$q$qvalues<0.1)
mu1<-c(rep(mean(y[group==1 & time==0,sig]),4),
rep(mean(y[group==1 & time==2,sig]),4),
rep(mean(y[group==1 & time==4,sig]),3),
rep(mean(y[group==1 & time==6,sig]),3),
rep(mean(y[group==1 & time==9,sig]),4),
rep(mean(y[group==1 & time==24,sig]),4),
rep(mean(y[group==2 & time==0,sig]),4),
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rep(mean(y[group==2
rep(mean(y[group==2
rep(mean(y[group==2
rep(mean(y[group==2
rep(mean(y[group==2

&
&
&
&
&

time==2,sig]),4),
time==4,sig]),4),
time==6,sig]),4),
time==9,sig]),4),
time==24,sig]),4))

sim.p<-NULL
sim.q<-NULL
rank.q<-NULL
for (i in 1:n){
ynew1<-mu1+sqrtr%*%(rnorm(46)*sqrt(var))
ysim<-cbind(y,ynew1)
simdata<-storey.sim(ysim,100)
sim.p<-c(sim.p,simdata$p[801])
sim.q<-c(sim.q,simdata$q$qvalues[801])
rank.q<-c(rank.q,rank(simdata$q$qvalues)[801])
}
sum.q<-sum(sim.q<=0.1)
sum.p<-sum(sim.p<=0.1)
rank.100<-sum(rank.q<=100)
}
}
if (method=="all")
{
if (gene=="null")
{
mu0<-c(rep(mean(y[group==1 & time==0,]),4),
rep(mean(y[group==1 & time==2,]),4),
rep(mean(y[group==1 & time==4,]),4),
rep(mean(y[group==1 & time==6,]),4),
rep(mean(y[group==1 & time==9,]),4),
rep(mean(y[group==1 & time==24,]),4))
mu0<-c(mu0[-c(9,13)],mu0)
sim.p<-NULL
sim.q<-NULL
rank.q<-NULL
for (i in 1:n){
ynew<-mu0+sqrtr%*%(rnorm(46)*sqrt(var))
ysim<-cbind(y,ynew)
simdata<-storey.sim(ysim,100)
sim.p<-c(sim.p,simdata$p[801])
sim.q<-c(sim.q,simdata$q$qvalues[801])
rank.q<-c(rank.q,rank(simdata$q$qvalues)[801])
}
sum.q<-sum(sim.q<=0.1)
sum.p<-sum(sim.p<=0.1)
rank.100<-sum(rank.q<=100)
}
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if (gene=="alt")
{
mu1<-c(rep(mean(y[group==1 & time==0,]),4),
rep(mean(y[group==1 & time==2,]),4),
rep(mean(y[group==1 & time==4,]),3),
rep(mean(y[group==1 & time==6,]),3),
rep(mean(y[group==1 & time==9,]),4),
rep(mean(y[group==1 & time==24,]),4),
rep(mean(y[group==2 & time==0,]),4),
rep(mean(y[group==2 & time==2,]),4),
rep(mean(y[group==2 & time==4,]),4),
rep(mean(y[group==2 & time==6,]),4),
rep(mean(y[group==2 & time==9,]),4),
rep(mean(y[group==2 & time==24,]),4))
sim.p<-NULL
sim.q<-NULL
rank.q<-NULL
for (i in 1:n){
ynew1<-mu1+sqrtr%*%(rnorm(46)*sqrt(var))
ysim<-cbind(y,ynew1)
simdata<-storey.sim(ysim,100)
sim.p<-c(sim.p,simdata$p[801])
sim.q<-c(sim.q,simdata$q$qvalues[801])
rank.q<-c(rank.q,rank(simdata$q$qvalues)[801])
}
sum.q<-sum(sim.q<=0.1)
sum.p<-sum(sim.p<=0.1)
rank.100<-sum(rank.q<=100)
}
}
if (method=="group")
{
if (gene=="null")
{
mu0<-c(rep(mean(y[group==1 & time==0,clusters[,2]==1]),4),
rep(mean(y[group==1 & time==2,clusters[,2]==1]),4),
rep(mean(y[group==1 & time==4,clusters[,2]==1]),3),
rep(mean(y[group==1 & time==6,clusters[,2]==1]),3),
rep(mean(y[group==1 & time==9,clusters[,2]==1]),4),
rep(mean(y[group==1 & time==24,clusters[,2]==1]),4))
mu0<-c(mu0[-c(9,13)],mu0)
sim.p<-NULL
sim.q<-NULL
rank.q<-NULL
for (i in 1:n){
ynew<-mu0+sqrtr%*%(rnorm(46)*sqrt(var))
ysim<-cbind(y,ynew)
simdata<-storey.sim(ysim,100)
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sim.p<-c(sim.p,simdata$p[801])
sim.q<-c(sim.q,simdata$q$qvalues[801])
rank.q<-c(rank.q,rank(simdata$q$qvalues)[801])
}
sum.q<-sum(sim.q<=0.1)
sum.p<-sum(sim.p<=0.1)
rank.100<-sum(rank.q<=100)
}
if (gene=="alt")
{
mu1<-c(
rep(mean(y[group==1 & time==0,clusters[,2]==3])-diff,4),
rep(mean(y[group==1 & time==2,clusters[,2]==3])-diff,4),
rep(mean(y[group==1 & time==4,clusters[,2]==3])-diff,3),
rep(mean(y[group==1 & time==6,clusters[,2]==3])-diff,3),
rep(mean(y[group==1 & time==9,clusters[,2]==3])-diff,4),
rep(mean(y[group==1 & time==24,clusters[,2]==3])-diff,4),
rep(mean(y[group==2 & time==0,clusters[,2]==3]),4),
rep(mean(y[group==2 & time==2,clusters[,2]==3]),4),
rep(mean(y[group==2 & time==4,clusters[,2]==3]),4),
rep(mean(y[group==2 & time==6,clusters[,2]==3]),4),
rep(mean(y[group==2 & time==9,clusters[,2]==3]),4),
rep(mean(y[group==2 & time==24,clusters[,2]==3]),4))
sim.p<-NULL
sim.q<-NULL
rank.q<-NULL
for (i in 1:n){
ynew1<-mu1+sqrtr%*%(rnorm(46)*sqrt(var))
ysim<-cbind(y,ynew1)
simdata<-storey.sim(ysim,100)
sim.p<-c(sim.p,simdata$p[801])
sim.q<-c(sim.q,simdata$q$qvalues[801])
rank.q<-c(rank.q,rank(simdata$q$qvalues)[801])
}
sum.q<-sum(sim.q<=0.1)
sum.p<-sum(sim.p<=0.1)
rank.100<-sum(rank.q<=100)
}
}
if (method=="curve")
{
if (gene=="alt")
{
mu.clust<-c(
rep(mean(y[group==1 &
rep(mean(y[group==1 &
rep(mean(y[group==1 &
rep(mean(y[group==1 &
rep(mean(y[group==1 &
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time==0,clusters[,2]==3]),4),
time==2,clusters[,2]==3]),4),
time==4,clusters[,2]==3]),3),
time==6,clusters[,2]==3]),3),
time==9,clusters[,2]==3]),4),

rep(mean(y[group==1
rep(mean(y[group==2
rep(mean(y[group==2
rep(mean(y[group==2
rep(mean(y[group==2
rep(mean(y[group==2
rep(mean(y[group==2

&
&
&
&
&
&
&

time==24,clusters[,2]==3]),4),
time==0,clusters[,2]==3]),4),
time==2,clusters[,2]==3]),4),
time==4,clusters[,2]==3]),4),
time==6,clusters[,2]==3]),4),
time==9,clusters[,2]==3]),4),
time==24,clusters[,2]==3]),4))

mu1<-c(mu.clust[1:22],(mu.clust[23:46]-17000)*.5+20000)
mu2<-c(mu.clust[1:22],(mu1[23:46]-20000)*.5+23000)
mu3<-c(mu.clust[1:22],(mu2[23:46]-23000)*.75+25000)
mu4<-c(mu.clust[1:22],(mu3[23:46]-25000)*.75+25500)
mu5<-c(mu.clust[1:22],(mu4[23:46]-25500)*.75+26000)

if
if
if
if
if
if

(diff==0)
(diff==1)
(diff==2)
(diff==3)
(diff==4)
(diff==5)

mu<-mu.clust
mu<-mu1
mu<-mu2
mu<-mu3
mu<-mu4
mu<-mu5

sim.p<-NULL
sim.q<-NULL
rank.q<-NULL
for (i in 1:n){
ynew1<-mu+sqrtr%*%(rnorm(46)*sqrt(var))
ysim<-cbind(y,ynew1)
simdata<-storey.sim(ysim,100)
sim.p<-c(sim.p,simdata$p[801])
sim.q<-c(sim.q,simdata$q$qvalues[801])
rank.q<-c(rank.q,rank(simdata$q$qvalues)[801])
}
sum.q<-sum(sim.q<=0.1)
sum.p<-sum(sim.p<=0.1)
rank.100<-sum(rank.q<=100)
}
}
if (method=="230")
{
if (gene=="alt")
{
mu.230<-c(
rep(mean(y[group==1
rep(mean(y[group==1
rep(mean(y[group==1
rep(mean(y[group==1
rep(mean(y[group==1
rep(mean(y[group==1
rep(mean(y[group==2
rep(mean(y[group==2

&
&
&
&
&
&
&
&

time==0,230]),4),
time==2,230]),4),
time==4,230]),3),
time==6,230]),3),
time==9,230]),4),
time==24,230]),4),
time==0,230]),4),
time==2,230]),4),
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rep(mean(y[group==2
rep(mean(y[group==2
rep(mean(y[group==2
rep(mean(y[group==2

&
&
&
&

time==4,230]),4),
time==6,230]),4),
time==9,230]),4),
time==24,230]),4))

mu1<-c(mu.230[1:22],(mu.230[23:46]-10000)*.5+7000)
mu2<-c(mu.230[1:22],(mu1[23:46]-7000)*.25+5000)
mu3<-c(mu.230[1:22],(mu2[23:46]-5000)*.1+4500)
if
if
if
if

(diff==0)
(diff==1)
(diff==2)
(diff==3)

mu<-mu.230
mu<-mu1
mu<-mu2
mu<-mu3

sim.p<-NULL
sim.q<-NULL
rank.q<-NULL
for (i in 1:n){
ynew1<-mu+sqrtr%*%(rnorm(46)*sqrt(var))
ysim<-cbind(y,ynew1)
simdata<-storey.sim(ysim,100)
sim.p<-c(sim.p,simdata$p[801])
sim.q<-c(sim.q,simdata$q$qvalues[801])
rank.q<-c(rank.q,rank(simdata$q$qvalues)[801])
}
sum.q<-sum(sim.q<=0.1)
sum.p<-sum(sim.p<=0.1)
rank.100<-sum(rank.q<=100)
}
}
return(sum.q,sum.p,rank.q,rank.100)
}
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B. TABULAR RESULTS FROM SIMULATION STUDY

Table B.1: Results of first attenuation simulation. The proportion of simulated genes
ranked in top 100 along with their standard errors (in parentheses). Vectors A–F
correspond to the vectors used to simulate the genes in Figure 4.5.
ρ
Mean vector

0

0.5

0.7

0.9

A

0.989 (0.003) 0.994 (0.002) 0.990 (0.003) 0.997 (0.002)

B

0.990 (0.003) 0.984 (0.004) 0.982 (0.004) 0.994 (0.002)

C

0.969 (0.005) 0.969 (0.005) 0.960 (0.006) 0.971 (0.005)

D

0.598 (0.016) 0.653 (0.015) 0.701 (0.014) 0.834 (0.012)

E

0.210 (0.013) 0.237 (0.013) 0.373 (0.015) 0.556 (0.016)

F

0.074 (0.008) 0.115 (0.010) 0.165 (0.012) 0.351 (0.015)
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Table B.2: Results of second attenuation simulation. The proportion of simulated
genes ranked in top 100 along with their standard errors (in parentheses). Vectors
A–D correspond to the vectors used to simulate the genes in Figure 4.7.
ρ
Mean vector

0

0.5

0.7

0.9

A

0.987 (0.004) 0.992 (0.003) 0.986 (0.004) 0.982 (0.004)

B

0.988 (0.003) 0.987 (0.004) 0.982 (0.004) 0.987 (0.004)

C

0.153 (0.011) 0.208 (0.013) 0.316 (0.015) 0.565 (0.016)

D

0.002 (0.001) 0.011 (0.003) 0.023 (0.005) 0.125 (0.010)

Table B.3: Results of simulation with σ 2 = 25, 000. The proportion of simulated
genes ranked in top 100 along with their standard errors (in parentheses). These
results were used to construct Figure 4.4.
ρ
Mean vector
Null/All

0

0.5

0.7

0.9

0.000 (0.000) 0.000 (0.000) 0.000 (0.000) 0.031 (0.005)

Null/Non-sig 0.000 (0.000) 0.000 (0.000) 0.002 (0.001) 0.034 (0.006)
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Null/Cluster

0.000 (0.000) 0.000 (0.000) 0.000 (0.000) 0.039 (0.006)

Alt/Sig

0.988 (0.003) 0.995 (0.002) 0.983 (0.004) 0.989 (0.003)

Alt/Cluster

0.989 (0.003) 0.985 (0.004) 0.993 (0.003) 0.985 (0.004)

Table B.4: Results of simulation with σ 2 = 250, 000. The proportion of simulated
genes ranked in top 100, along with their standard errors (in parentheses). These
results were used to construct Figure 4.4.
ρ
Mean vector
Null/All

0

0.5

0.7

0.9

0.000 (0.000) 0.000 (0.000) 0.001 (0.001) 0.040 (0.006)

Null/Non-sig 0.000 (0.000) 0.000 (0.000) 0.001 (0.001) 0.039 (0.006)
Null/Cluster

0.000 (0.000) 0.000 (0.000) 0.002 (0.001) 0.034 (0.006)

Alt/Sig

0.075 (0.008) 0.112 (0.010) 0.223 (0.013) 0.427 (0.016)

Alt/Cluster

0.989 (0.003) 0.994 (0.002) 0.990 (0.003) 0.997 (0.002)

Table B.5: Results of simulation with σ 2 = 2, 500, 000. The proportion of simulated
genes ranked in top 100 along with their standard errors (in parentheses). These
results were used to construct Figure 4.4.
ρ
Mean vector
Null/All

0

0.5

0.7

0.9

0.000 (0.000) 0.000 (0.000) 0.000 (0.000) 0.040 (0.006)

Null/Non-sig 0.000 (0.000) 0.000 (0.000) 0.001 (0.001) 0.029 (0.005)
Null/Cluster

0.000 (0.000) 0.001 (0.001) 0.002 (0.001) 0.037 (0.006)

Alt/Sig

0.000 (0.000) 0.002 (0.001) 0.004 (0.002) 0.072 (0.008)

Alt/Cluster

0.984 (0.004) 0.991 (0.003) 0.987 (0.004) 0.984 (0.004)
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Table B.6: Results of first attenuation simulation (average rankings). The average
ranking of simulated genes along with their standard errors (in parentheses). Vectors
A–F correspond to the vectors used to simulate the genes in Figure 4.5. These results
were used to construct Figure 4.6.

ρ
Mean vector

0

0.5

0.7

0.9

A

76.18 (11.75)

75.93 (11.56)

75.93 (11.49)

76.00 (11.37)

B

75.59 (11.66)

76.18 (11.32)

75.64 (12.35)

76.30 (10.67)

C

77.97 (15.40)

78.03 (15.71)

78.92 (18.46)

77.87 (17.90)

D

128.59 (72.39)

119.52 (69.26)

114.74 (68.68)

98.72 (59.01)

E

227.30 (107.43) 224.49 (117.81) 197.11 (120.85) 158.52 (113.18)

F

320.92 (125.77) 300.86 (136.65) 272.72 (136.86) 207.51 (131.20)

Table B.7: Results of second attenuation simulation(average rankings). The average
ranking of simulated genes along with their standard errors (in parentheses). Vectors
A–D correspond to the vectors used to simulate the genes in Figure 4.7. These results
were used to construct Figure 4.8.

ρ
Mean vector

0

0.5

0.7

0.9

A

76.05 (11.36)

75.84 (11.57)

76.20 (11.90)

75.95 (11.39)

B

75.88 (11.49)

75.88 (11.12)

76.35 (11.65)

75.95 (11.66)
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C

263.96 (125.55) 251.90 (132.72) 217.12 (128.58) 151.20 (108.49)

D

554.06 (144.80) 514.39 (154.42) 476.70 (173.01) 358.82 (181.91)

Table B.8: Results of simulation with σ 2 = 25, 000 (average rankings). The average
ranking of simulated genes along with their standard errors (in parentheses).

ρ
Mean vector

0

0.5

0.7

0.9

Null/All

698.03 (94.35)

670.14 (113.18) 620.46 (138.40) 491.49 (184.91)

Null/Non-sig 700.40 (91.34)

658.15 (121.99) 613.12 (139.59) 483.64 (181.10)

Null/Cluster

699.72 (96.61)

661.37 (119.29) 605.16 (140.56) 478.40 (185.49)

Alt/Sig

75.40 (11.51)

75.73 (11.19)

75.98 (11.79)

76.34 (11.36)

Alt/Cluster

75.72 (11.98)

75.63 (11.66)

75.43 (11.05)

76.58 (11.86)

Table B.9: Results of simulation with σ 2 = 250, 000 (average rankings). The average
ranking of simulated genes along with their standard errors (in parentheses).

ρ
Mean vector

0

Null/All

695.82 (97.01)

653.57 (123.73) 609.95 (140.38) 478.87 (186.85)

Null/Non-sig

696.70 (95.11)

665.55 (115.25) 612.38 (141.45) 483.31 (185.14)

Null/Cluster

691.58 (100.05) 661.61 (119.12) 613.76 (142.34) 480.36 (183.84)

Alt/Sig

339.39 (141.80) 302.11 (138.75) 264.28 (145.31) 205.41 (144.88)

Alt/Cluster

76.18 (11.75)

0.5

75.93 (11.56)

0.7

75.93 (11.49)

0.9

76.00 (11.37)
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Table B.10: Results of simulation with σ 2 = 2, 500, 000 (average rankings). The
average ranking of simulated genes along with their standard errors (in parentheses).

ρ
Mean vector
Null/All

0

0.5

0.7

0.9

696.50 (100.86) 656.71 (117.76) 608.74 (142.66) 484.35 (187.55)

Null/Non-sig

698.73 (94.65)

657.66 (117.66) 609.05 (138.22) 477.91 (183.00)

Null/Cluster

699.39 (96.33)

658.90 (122.14) 612.86 (142.36) 481.60 (190.66)

Alt/Sig
Alt/Cluster
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644.39 (122.56) 599.76 (145.34) 557.20 (154.90) 439.42 (193.28)
76.19 (11.93)

76.38 (11.11)

76.04 (11.49)

76.63 (11.37)

